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Animal life must carefully balance energetic resources with physiological demands to promote 
growth and ensure survival. Energy serves as a valuable resource to cope with ever-changing 
environmental demands and requires complex regulatory networks to ensure efficient energy 
utilization. In mammals, PGC-1α (Peroxisome Proliferator Activated Receptor Co-Activator 1 α) 
is a master regulator of metabolism coordinating many essential metabolic processes. However, 
the importance of PGC-1α is currently unknown amongst lower vertebrates, despite controversy 
suggesting divergent roles for PGC-1α in teleost species. Here, I describe the creation of a 
mutant zebrafish line dedicated to uncovering the role of PGC-1α in zebrafish. In chapter 2, I 
disrupted an evolutionary conserved region upstream of the PGC-1α promoter, simultaneously 
increasing PGC-1α expression in skeletal muscle 4-fold and decreasing PGC-1α expression in 
cardiac muscle 4-fold. This mutation increased O2 consumption in white muscle fibres and 
doubled the resting metabolism in juvenile zebrafish demonstrating that PGC-1α retains its role 
as a metabolic regulator in fish. In chapter 3, I hypothesized that PGC-1α mutant zebrafish 
experience impaired growth due to having a decreased metabolic efficiency. Mutant zebrafish 
larvae displayed decreased heart rate alongside increased yolk fatty acid (FA) content, indicating 
decreased FA metabolism during early development. Surprisingly, mutant adult zebrafish had 
increased FA metabolism, resisted growth when presented with a high-fat diet and decreased 
Dihomo-Gamma-Linoleic-Acid in skeletal muscle, a FA that prevents mitochondrial leakage. In 
summary, this mutation greatly impedes the metabolic function of zebrafish and provides a 
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Chapter 1: Introduction 
1.1 Bioenergetics and Energy Importance 
All organisms require energy in order to survive and thrive in their environment. Every animal, 
regardless of size, must therefore be able to derive energy from dietary nutrients and utilize these 
resources strategically to maximize energy gain while minimizing energy loss. Although a 
simple concept at the surface level, the process of energy management relies on many factors 
such as external stimuli (diet, environmental conditions and predation) and internal processes 
(energy reserves, genetic factors and cellular pathways). Metabolic diseases arise from impaired 
nutrient usage in living cells, resulting in morbidities such as chronic obesity, heart disease, 
Parkinson’s disease amongst others (Neves et al., 2014; Ostojic, 2017; Spiegelman & Flier, 
2001). Although many of these diseases have allowed for remarkable advancements in both 
medical knowledge and the importance of bioenergetics in everyday life, they continue to 
become more prevalent within our population with each passing day (Saklayen, 2018).  
In 1998, the discovery of the metabolic coactivator termed ‘Peroxisome Proliferator Activated 
Receptor Gamma Co-activator 1 α (PGC-1α) led to rapid increases in our understanding of 
metabolic regulation (Puigserver et al., 1998). The PGC-1α protein is expressed in a variety of 
metabolically active tissues and coordinates 1000’s of genes involved in tissue remodeling and 
bioenergetic processes. Researchers have studied PGC-1α using in vitro and in vivo approaches 
featuring human cell lines and mammalian models, however, many subtle functional aspects of 
PGC-1α remain unclear (Austin & St-Pierre, 2012; Besse-Patin et al., 2019; Geng et al., 2010; 
Russell et al., 2004). This ambiguity largely stems from the complexity of working with an 
advanced evolutionary model, as mammalian PGC-1α is implicated in a variety of key metabolic 
pathways that exponentially complicates the study of the role of the protein. An alternative 
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approach focusing on an evolutionarily distant model might therefore provide additional 
information on this coactivator by excluding many of the later acquired regulator roles of the 
protein. Hence, the study of PGC-1α in zebrafish may help to identify key core regulatory roles 
that are unable to be detailed in mammals, or to provide further clarification on currently 
controversial aspects of PGC-1α regulation. 
1.2 Nutrients 
Energetic resources must first be obtained, consumed and metabolized in order to provide energy 
for animals. All nutrients are derived from living organisms, such as plants or animals. They can 
be categorized into two major groups according to their general abundance and origin. 
Micronutrients (vitamins, minerals, and trace minerals) are present in limited quantities and serve 
various roles throughout the body, often associated with the immune system and enzyme 
function. In contrast, macronutrients (carbohydrates, lipids, and proteins) are plentiful and serve 
as primary building blocks for cellular structures in addition to being used as energy resources 
(Chen et al., 2018). All macromolecules can persist as either monomers or polymers as defined 
by the cell, allowing for them to readily assessable for catabolism or to be stored for extended 
periods of time (Deberardinis & Thompson, 2012).  While similar in these aspects, each 
macromolecule monomer is structurally unique, creating a need for multiple energy pathways 
that occur at the cellular level.  
Carbohydrates serve as the main macronutrient for humans and are often described as large 
repetitive molecules, consisting of simple sugars or starches produced by plant photosynthesis 
(Stetten & Topper, 1955). After consumption, carbohydrates are broken down into simple sugars 
(e.g., glucose) that can be imported into cells for immediate energy or converted into glycogen 
by the liver for storage. Glycogen molecules are stored in the liver and skeletal muscle and can 
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provide glucose during long fasting periods or in response to physical exercise, effectively acting 
as a carbohydrate buffer for the body. In vertebrates, glycogen stores are adequately maintained 
by the pancreas through insulin secretion in response to rising blood sugar levels, ensuring that 
glycogen stores are fully replenished following carbohydrate rich meals. However, with 
excessive carbohydrate consumption insulin can also promote the conversion of glucose into 
fatty acids in adipose tissue to further reduce blood sugar levels (Aronoff et al., 2004; Kersten, 
2001; Roach et al., 2012). These negative feedback mechanisms work together in order to satisfy 
immediate energetic demands while also creating additional energy reserves for future use during 
unfavourable conditions.  
Dietary lipids, specifically triglycerides, are exceptional molecules for energy storage as they 
contain a high caloric density in comparison to carbohydrate molecules. Triglyceride molecules 
can be obtained either through dietary means or created de novo following lipogenesis. They are 
built with glycerol backbone bound to single or multiple hydrocarbon chains in a variety of 
lengths with distinct hydrophobic and hydrophilic regions. In addition, lipids can also contain 
double bonds between carbon molecules, allowing for them to be further categorized as either 
saturated or unsaturated fatty acids. These combined characteristics allow for the creation of 
>1000 structurally distinct lipids, with unique properties to fulfill specialized roles in the cell 
such as maintaining membrane stability and acting as signaling molecules (Tracey et al., 2018). 
Aside from their multitude of cellular uses, lipids are energetically dense and can also serve as an 
important fuel source for tissues, by being stored and released from adipose cells into the 
bloodstream as free fatty acids (FFAs) which can then be transported into cells and metabolized. 
In addition to carbohydrates and lipids, proteins may also provide energy, however, proteins are 
much more complex in both structure and function when compared to the previous two 
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macromolecules. Unlike carbohydrates or lipids that consist of varying lengths of carbon 
molecules, proteins are made from amino acids. This group is comprised of 20 molecules that 
differ in size, charge and hydrophobicity to create a vast number of functional proteins (Ellington 
& Cherry, 1996). All amino acids share amino and carboxyl regions that can be linked together 
following condensation reactions, resulting in large chains of amino acids that can be folded to 
create functional proteins. Folded proteins maintain their conformation due to strong 
intermolecular bonds and their unique characteristics allow for proteins to have unique functions 
that are crucial for cellular function, but many of these processes rely on cellular energy in order 
to be effective. In periods of extreme starvation (or excess protein intake), amino acids can also 
be broken down further by energy-deprived cells following glucogenic or ketogenic pathways 
(Gurina & Mohiuddin, 2020). 
1.3 Nutrient Breakdown 
Energy rich macromolecules must be first be broken down by a series of enzymatic reactions in 
order to release usable energy for the cell. Although macromolecules differ in their chemical 
structure, they all contain strongly linked covalent bonds that release large amounts of energy 
when broken (Cooper & Klymkowsky, 2013). This energy is captured by carrier molecules 
(either NADH or FADH) and later used to create ATP (Adenosine Triphosphate) molecules, a 
stabilized cellular energy molecule used throughout the body. Nutrients can be metabolized by 
aerobic (requiring oxygen) or anaerobic (without oxygen) degradation pathways depending on 
substrate structure, energetic demands and oxygen availability. Aerobic pathways are more 
efficient in extracting macronutrient energy in comparison to anaerobic pathways, however this 
efficiency requires a lengthy series of chemical reactions in order to maximize energetic output 
with O2 usage. In contrast, anaerobic pathways are much faster and release energy without 
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needing to rely on O2 levels but produces metabolic wastes.  These aspects have restricted lipids 
and ketones to aerobic pathways as they contain many bonds and require extensive degradation 
to liberate energy. In contrast, glucose is structurally simpler and can be easily broken down into 
pyruvate following glycolysis; which can then be degraded by anerobic fermentation for 
immediate energy release or processed aerobically for higher energetic returns in the 
mitochondria (Cantrell & Mohiuddin, 2020; Sahlin et al., 1998). 
Glycolysis occurs in the cytosol where individual glucose molecules are broken down into two 
pyruvate molecules. This process requires 2 ATP molecules to initiate the cleavage of each 
glucose, however the 2 resulting pyruvate molecules can release additional energy by either 
anaerobic fermentation or aerobic oxidative phosphorylation. Fermentation reduces pyruvate into 
lactic acid in order to provide 4 ATP molecules in the absence of oxygen, effectively doubling 
the cell’s initial energy investment (Lunt & Vander Heiden, 2011). However, this amount is 
greatly reduced when compared to the total energetic output of oxidative phosphorylation, a 
process that generates 32 ATP molecules for each glucose molecule. This increased energy gain 
is due to the extended degradation of pyruvate occurring inside the mitochondria.  
1.4 Mitochondrial Structure  
Mitochondria are commonly referred to as the ‘powerhouse’ of the cell, as their primary role is 
to convert energy from electron carriers into ATP using a system of transcellular proteins and O2 
molecules. Mitochondria are densely populated around the endoplasmic reticulum, as close 
proximity allows for lipid exchange, fission/fusion, and mitochondrial-dependant signalling 
pathways to be initiated following input form the host cell (Marchi et al., 2014). Additionally, 
mitochondria are highly abundant in skeletal muscle tissues and aggregate between myofibrils 
where ATP is heavily needed. Mitochondria have two distinct compartments separated by two 
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membranes; the outer mitochondrial membrane, the intermembrane space, the inner 
mitochondrial membrane and the internal matrix (McCarron et al., 2013). The outer membrane 
contains many porins, open channels that allow for the passage of ions and small molecules into 
the mitochondrial intermembrane space from the cytoplasm. Once inside, molecules must bind to 
specific transporter proteins in order to cross the inner mitochondrial membrane. These 
transporter proteins help to restrict ion movement across the inner mitochondrial space in order 
to maintain an electrochemical gradient required for powering oxidative phosphorylation. 
Finally, the core of the mitochondria contains the mitochondrial matrix, a space containing a 
variety of enzymes that power the Krebs cycle, a series of reactions that harvest electrons from 
macromolecules prior to oxidative phosphorylation.  
1.5 The Krebs Cycle 
The Krebs cycle is a fundamental part of oxidative metabolism, as it provides a universal 
degradation pathway for all 3 macromolecules (carbohydrates, lipids and proteins). Prior to 
entering the Krebs cycle, macronutrients must first be converted into acetyl CoA (Acetyl 
Coenzyme A), which can be generated following glycolysis (from carbohydrates), β-oxidation 
(from lipids) or from deamination (from proteins). Upon entering the Krebs cycle, Acetyl CoA is 
readily converted with endogenous oxaloacetate to form citrate; the first of 9 stepwise 
modifications that ultimately result in 1) the release of 2 CO2 molecules and 2) 4 electrons 
deposited in the form of NADH and FADH2 and a Guanosine Triphosphate energy molecule. 
Following the release of CO2, oxaloacetate is returned to renew the reaction process for 
additional Krebs cycles, allowing for more Acetyl CoA molecules to be degraded for energy 
harvesting (Gnaiger, 2014). The electrons contained by NADH and FADH2 molecules can then 
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be transported to the Electron Transport System (ETS) where they can power oxidative 
phosphorylation and create energy in the form of ATP. 
1.6 Electron Transport System 
The Electron Transport System consists of 6 separate proteins (Complex I-IV, ubiquinone and 
cytochrome c) that work together in order to power oxidative metabolism through electron 
transport. Electrons gained from the Krebs cycle travel through the ETS proteins forcing 
unidirectional movement of hydrogen ions from the mitochondrial matrix to the inner 
mitochondrial space, establishing an electrochemical gradient across the inner membrane. As this 
gradient increases with subsequent electron transfer, hydrogen ions flux back to the mitochondria 
matrix by passing through ATP synthase (Complex V), the final protein in the ETS generating 
cellular energy in the form of Adenosine Triphosphate (ATP) (Maloney et al., 1974). These ATP 
molecules can then be used for a wide variety of cellular processes such as intercellular 
signalling, DNA/RNA synthesis, ion gradient maintenance and muscle contraction (Dunn & 
Grider, 2020). As ATP is a vital resource for the cell, mitochondrial function is crucial to provide 
a constant and reliable stream of energy for the organism. 
1.7 Origin of Mitochondria 
The origin of mitochondria is believed to stem approximately 1 billion years ago following an 
endosymbiotic event where two unicellular organisms fused, creating the first common ancestor 
of all eukaryotic life (Chernikova et al., 2011; Martin & Müller, 1998). These two organisms 
consisted of a larger prokaryotic cell dependent on the phagocytosis of smaller microorganisms 
and a smaller hydrogen-dependant bacterium capable of producing its own energy at the cost of 
expelling toxic reactive oxygen species. Following endosymbiosis, the two cells developed a 
mutual relationship where the host prokaryotic cell would provide protection to the smaller 
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bacterium by neutralizing oxidative stress while also becoming energetically self-sufficient 
(Roger et al., 2017). With time, the two organisms continued to survive as a single entity as an 
independent organism capable of producing its own cellular energy.  
Throughout the billions of years following this initial endosymbiosis, the cell and mitochondria 
have fostered an intimate relationship due to the major restructuring of genetic regulatory 
pathways. Most of the mitochondrial genes were relocated to the nucleus of the cell, leaving the 
modern day animal nucleus responsible for producing over 1500 mitochondrial proteins in 
comparison to the 22 unique tRNA molecules, 2 rRNA subunits and 13 ETS proteins still 
encoded by the mitochondrial genome (Jadiya & Tomar, 2020). This genetic shift has gradually 
allowed for the cell to gain control over mitochondrial mechanisms allowing for increased 
energy production and efficiency that is required for giving rise to multicellular organisms and 
specialized tissue types. As a result, eukaryotic life has become incredibly diverse with many 
adaptations that are heavily reliant on the power produced by the mitochondria. However, with 
great power also comes great responsibly as cells must regulate these energetic pathways in an 
efficient but reliable manor to ensure viability for both independent cells and the organism itself. 
1.8 Nuclear Receptors & Transcription Factors  
The nucleus is responsible for storing the cell’s genomic DNA and regulating the expression of 
genes required for normal cell function. In multicellular organisms, the genomic DNA is quite 
large and must be physically compressed using histone proteins, leaving only a small portion of 
the genome freely accessible to cellular machinery at any given moment (Evans & Williams, 
2002). These regions can then be activated by Transcription Factors (TFs), a class of proteins 
responsible for facilitating transcription; the process of converting DNA into mRNA transcripts 
typically used for protein synthesis. This process is highly complex, as TFs often work together 
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alongside co-activator,co-repressor and chromatin remodelling proteins to consolidate the 
regulation of every genetic element in the host cell (Kuntz et al., 2012; Spitz & Furlong, 2012). 
Additionally, many of these regulatory pathways are primarily activated by external ligands 
through a subset of TFs known as the Nuclear Receptors (NRs). These NRs often serve as the 
initial activation point for activating gene expression as their ligands are representative of 
environmental and internal cellular conditions (Avior et al., 2013).  
To date, 48 NRs have been identified in humans and further categorized into 3 subgroups based 
on their physiological functions and corresponding ligands; Endocrine Receptors, Orphan 
Receptors and Adopted Orphan Receptors (Sonoda et al., 2008; Weikum et al., 2018). Endocrine 
Receptors are regulated by circulating hormones and vitamins, many of which are well 
documented in the literature due to their prominent effects in both normal hormone-induced 
development and in various pathologies. In contrast, the appropriately named ‘Orphan 
Receptors’ have no known ligands, resulting in limited information regarding their physiological 
function and role. With recent advancements in cellular biology, many of these ligands have 
been discovered and paired with their respective NRs, allowing for some of the Orphan 
Receptors to be reclassified as ‘Adopted Nuclear Receptors’ (De Vera, 2018). Although some of 
the Adopted Nuclear receptors are activated by non-biological molecules (xenobiotics), a vast 
majority are activated by dietary lipids such as phospholipids, cholesterol and fatty acids 
(Sonoda et al., 2008). Given that these dietary lipids reflect the metabolic state of the organism, it 
should be of no surprise that many of these receptors play important roles in the regulation of 
cellular bioenergetics. 
The cell relies on mitochondrial-specific TFs in order to regulate both energetic and non-
energetic mitochondrial processes between the nuclear and mitochondrial genomes (Kelly & 
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Scarpulla, 2004; Leigh-Brown et al., 2010). As these genomes are physically separated in the 
cell, mitochondrial genes can only be activated in the presence of specific mitochondrial TFs, 
which are transcribed by the nucleus. Each mitochondrial TF is responsible for the activation of a 
subset of mitochondrial genes in response to a particular activating ligand (Table 1). Although 
some TFs feature redundant roles, different ligands allow for the cell to selectively respond to 
specific stimuli. These ligands allow for TFs to adjust mitochondrial performance across 
multiple cell types in accordance with energetic demands, serving a vital role for multicellular 
organisms. As such, these TFs remain highly conserved amongst animal species and must be 
tightly regulated to ensure metabolic stability.  
Table 1-1: Metabolically relevant transcription factors and their associated ligands 
Transcription 
Factors 
Activating Ligand Regulatory Roles 
Nuclear 
Respiratory Factor 
1 & 2  
(NRF-1 & NRF-2) 
Environmental Stimuli 
(Exercise) and various 
hormones 
Transcription of ETS proteins, Heme synthesis, mtDNA 
transcription & replication machinery (Activation of 
TFAM), Mitochondrial biogenesis, Mitochondrial protein 
transporters and ion channels (Kelly & Scarpulla, 2004; 





Transcription of FAO enzymes (MCAD), FA transport, 
Glucose/Glycogen transport, Mitochondrial biogenesis, 
Mitochondrial respiratory chain enzymes, Muscle 
contraction elements (Huss et al., 2004; Mootha et al., 
2004) 
Thyroid Hormone 
T3 Receptor (THR) 
Thyroid Hormone (T3) 
Inner mitochondrial membrane proteins, Mitochondrial 
biogenesis (Activation of NRF-1), Mitochondrial fat and 
carbohydrate transporters, Mitochondrial uncoupling 
(Thermogenesis), mtDNA transcription (Activation of 
TFAM), Mitochondrial ion channels, Mitochondrial fat 
and carbohydrate transporters (Cioffi et al., 2013; Harper 








Mediates mtDNA transcription & replication (Kang et al., 







Transcription of FA transporters and FAO enzymes 
(Berger & Moller, 2002; Grygiel-Górniak, 2014; Tyagi et 
al., 2011) 
1.9 Transcriptional Co-Regulators & PGC-1α 
Transcriptional co-activators and co-repressors provide the cell with an alternative approach to 
modifying and coordinating TF and NR activity. These proteins are arguably the most intricate 
players for transcriptional regulation as they are tightly regulated by the cell in relatively low 
abundance to oversee the activity of TFs or NRs (Bulynko & O’Malley, 2011; Rosenfeld et al., 
2006). Ultimately, these proteins serve as the final decision makers towards enabling specific 
transcriptional patterns with small differences in their expression leading to vast phenotypic 
differences. From a metabolic perspective, an organism must be capable of balancing both 
energy acquisition and expenditure in order to grow and survive. These extremely important 
roles require intricate control over the various metabolic pathways in the cell, as activation of 
conflicting pathways could present lethal consequences to individual cells and compromise the 
overall health of the organism (Giudici et al., 2015).  
One of the most notorious regulators of overall metabolism is Peroxisome Proliferator Activated 
Receptor Gamma Co-activator 1 α (PGC-1α), a protein responsible for controlling the expression 
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of a vast number of metabolic genes (Puigserver & Spiegelman, 2003). With its discovery in 
1998, researchers determined that murine PGC-1α directly promoted thermogenesis by 
upregulating UCP-1 (Uncoupling Protein) in Brown Adipose Tissue (BAT), effectively 
modifying mitochondria to dissipate heat instead of cellular energy (Puigserver et al., 1998). This 
discovery led to increased PGC-1α research in the following years, which uncovered many 
metabolic roles associated with PGC-1α’s activation of TFs and NRs. This includes roles in fatty 
acid oxidation, muscle fibre-type switching, mitochondrial biogenesis and heart development 
(Table 2). As a result, PGC-1α is often regarded as a ‘master regulator’ of overall metabolism as 
it coordinates many complex metabolic pathways to provide energetic stability throughout the 
entire body. Additionally, two paralogues were later discovered and termed PGC-1β and PRC 
(PGC-related co-activator), however both proteins have been highly overshadowed by PGC-1α 
resulting in relatively limited knowledge about their regulatory roles (Austin & St-Pierre, 2012; 
J. Lin et al., 2005). This is mainly due to irregularities in PGC-1α expression acting as a hallmark 
of many metabolic diseases, indicating that PGC-1α function is imperative when it comes to 
understanding the underlying causes of cardiovascular diseases, neurodegenerative diseases, 
cancer, obesity and diabetes (Austin & St-Pierre, 2012; Handschin & Spiegelman, 2008; Wenz, 
2011). 
The immense complexity of the PGC-1α regulatory network presents unique challenges for 
researchers wishing to study this important co-activator. Early PGC-1α studies utilized 
adenoviral vectors to overexpress PGC-1α in murine tissues and cell culture lines to provide 
experimental approaches to PGC-1α discovery. However, as a metabolic co-activator PGC-1α 
activity is heavily influenced by both environmental and cellular factors which must both be 
controlled in order to examine the true roles of the protein. Furthermore, later findings 
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demonstrated that PGC-1α could be influenced by cross-tissue regulatory networks, effectively 
limiting the knowledge gained by traditional isolation techniques (Balampanis et al., 2019). As a 
result, modern PGC-1α research is primarily conducted in multicellular organisms with altered 
PGC-1α expression profiles using genetic modification techniques, such as CRISPR, morpholino 
injections, or Cre-Lox recombination (J. Lin et al., 2004). These techniques aim to toggle or 
disable PGC-1α expression to explore distinct phenotypes and genetic pathways associated with 
PGC-1α activity. Surprisingly, -/- PGC-1α whole body knockouts in mice remain viable despite 
its relatively important roles in individualized tissues, suggesting that PGC-1α might activate 
only in response to alterations in metabolic states (Arany et al., 2005; J. Lin et al., 2004; Wende 
et al., 2007). 
Further studies on PGC-1α have examined the protein with excessive (or absence) of 
bioenergetic stimuli to provoke further regulatory behaviour. Such conditions included long 
fasting periods, overfeeding with high caloric or fat diets and extensive exercise; all implemented 
in the genetic models discussed previously. As expected, these studies were successful at 
evoking additional PGC-1α phenotypes in wildtype and +/+ PGC-1α mice proving that PGC-1α 
responds to changes in diet and exercise (Geng et al., 2010; Handschin & Spiegelman, 2008; 
Wende et al., 2007; Wilson, 2017). These results are not surprising as both diet and exercise 
directly alter nutrient consumption and energy output, however they suggest that PGC-1α plays 
an important role in mediating energetic ‘supply and demand’. These studies have been very 
helpful in the determination of overall PGC-1α function; however the underlying regulatory 
mechanisms (TF activation) remain variable in the literature. Overall, these results indicate that 




Table 1-2. Cell culture experiments featuring PGC-1α interactions with transcription factors and their resulting 
phenotypes. 
Tissue Type Transcription Factor Phenotype 
Brown Fat 
PPARγ,  
THR (Thyroid Hormone 
Receptor),  
ERα (Estrogen Receptor),  
RARα (Retinoic Acid Receptor 
α) 
Increased Thermogenesis (Puigserver 




Increased Mitochondrial Biogenesis, 
Decreased Mitochondrial Uncoupling 
(Lehman et al., 2000) 
PPARα Increased FAO (Huss et al., 2002) 
Skeletal Muscle 
NRF-1, NRF-2 Increased Mitochondrial Biogenesis, 
Thermogenesis (Wu et al., 1999) 
PPARβ Increased FAO (Y. X. Wang et al., 
2003) 
Liver 
HNF-4a (Hepatocyte Nuclear 
Factor 4 α) 
Increased Gluconeogenesis (Herzig 
et al., 2001; Yoon et al., 2001), 
ERα N.D. (Tcherepanova et al., 2000) 
PXR (Pregnane X Receptor) Glucose/Cholesterol Metabolism 
(Bhalla et al., 2004) 
PPARγ, HNF-4a, FNX 
(Farnesoid X Receptor) 
Increased FAO (Zhang et al., 2004) 
Kidney 
PPARα Increased FAO (Vega et al., 2000) 
PPARβ Increased FAO (Y. X. Wang et al., 
2003) 
ERRα Increased FAO (Schreiber et al., 
2003) 
White Fat 




Table 1-3: Phenotypes Produced by Various PGC1a Mouse Models 

























1.5 - 2.5x Increase 
(across all tissues) 










ndrial enzymes (liver), 
Decreased FA content 




















Absent in Heart, 
BAT, Muscle 





Decreased thermogenesis with matched UCP-1 
expression (BAT), 
No difference in blood glucose/sensitivity in females 
but greater sensitivity in males (blood), loss in brain 
structural integrity (brain), Decreased heartrate and left 
ventricle fractional shortening following exercise 
(heart), Decreased cardiac output at rest (heart), Fatty 
liver after fasting (liver), Reduced FAO through S2+S3 
(liver), Reduced tissue mass (heart, muscle), Fewer / 
Smaller Mitochondria and fewer mitochondrial 
enzymes (muscle), Reduced S3 O2 consumption 
(muscle), Reduced physical endurance following 
exercise (whole body), Lower body mass following 
birth but higher during adulthood (whole body), Higher 
% body fat during adulthood more-so in females (whole 
body) (Leone et al., 2005) 
 





1α) (Arany et 
al., 2005; J. 
Lin et al., 
2004; Wende 
et al., 2007) 
 
Absent in Liver, 
Muscle, BAT 
(Arany et al., 
2005; J. Lin et 
al., 2004; 
Wende et al., 
2007) 
 
Resistant to obesity (adipose), Decreased 
thermogenesis (BAT), Striatum lesions (brain), 
Decreased neurite branches (brain), Decreased 
gluconeogenic enzymes (liver), Decreased 
FAO/Mitochondrial enzymes (muscle), Increased O2 
consumption (whole body) (J. Lin et al., 2004) 
Increased glucose and glycogen levels post-exercise 
(muscle), Decreased GLUT4 expression (muscle), 
Decreased running distance (muscle) (Wende et al., 
2007), 
 
No difference in cardiac structure or mitochondrial 
content (heart), Decreased CPT1, CPT2 proteins and 
‘lower’ PPARα, ERRα, NRF-1 expression (heart), 
Decreased cardiac performance (heart), Decreased 
fractional shortening (heart), Decreased ATP and PCr 
(heart), Increased cardiac stress and dysfunction at late 
age (heart), slight increase in oxidative fibres (muscle), 
decreased mitochondrial enzymes in isolated cells 






























biogenesis, cardiac edema 









via TRE promoter 
(Russell et al., 
2004) 
 
N.D Increased mitochondrial 
density and volume, 
Decreased myofibrillar 
density, Increased NRF-1 
expression, No difference 
in FAO CPT-1 or MCAD 
expression, Cardiac 
biventricular dilation, 
Increased mortality via 
cardiac disfunction, 
Reduced fractional 
shortening (Russell et al., 
2004) 






and Knockout via 
TRE-promoter 






enzymes, Increased type I 
fibre related genes, More 
prominent redness in 
mixed-muscle, Increased 
cyt. c, myoglobin 
expression in white 






















promoter (J. Lin 
et al., 2002) 
 
Increased 




type I muscle 




enzymes, Increased type I 
fibre related genes, More 
prominent redness in 
mixed-muscle, Increased 
cyt. c, myoglobin 
expression in white 










(Geng et al., 
2010) 
 
Exercise induced mitochondrial biogenesis, Increased 
physical endurance following exercise, No effect on 







1.10 Evolutionary Differences in PGC1α 
The majority of current PGC-1α research has been conducted in mammals, however the function 
of the protein remains elusive in other vertebrate models (LeMoine et al., 2010; Siepel et al., 
2005). Vertebrates have diverged greatly over the past 370 million years following multiple 
whole genome duplication events (Kumar & Hedges, 1998). These events created functionally 
identical copies of pre-existing genes, increasing genetic redundancy and eventually resulting in 
the divergence of duplicated genes resulting in various outcomes including retained and newly 
derived functions (Force et al., 1999; Meyer & Schartl, 1999). Excluding mammals and birds, 
most vertebrates (fish, amphibians and reptiles) are ectothermic and lack BAT or endogenous 
capacity to produce heat, relying on heat from the environment to maintain body temperature 
(Else & Hulbert, 1981; Zotin, 2018). Primitive forms of the PGC1 family genes can be found in 
invertebrate species (drosophila, mosquito and sea squirt lineages), however the divergence of 
PGC-1α/β was believed to occur after the first whole genome duplication event during early 
chordate evolution. An extensive study examining the phylogeny of PGC-1α transcripts revealed 
that the amino and carboxyl termini are highly conserved throughout vertebrates, however the 
internal segment featuring the NRF-1 and MEF2c binding domains experienced increased 
variation in ray-finned fish species (LeMoine et al., 2010). Additionally, multiple fish species 
contain serine and glutamine insertions inside the NRF-1 and MEF2c domains that could alter 
PGC-1α interactions with these proteins, as suggested by studies that have examined NRF-1 and 
PGC-1α activity in goldfish (Katharina Bremer et al., 2012; LeMoine et al., 2008, 2010). 
Ultimately, these variant sections of the PGC-1α protein suggest that PGC-1α regulation in lower 
vertebrates may not be identical to those reported in mammalian models (LeMoine et al., 2008, 
2010). With the majority of PGC-1α research focused on mice and human cells, our knowledge 
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of PGC-1α in other vertebrates is limited. Hence, there is a need for a genetically altered 
organism from the vertebrate linage to provide a suitable model for the investigation of PGC-1α 
in non-mammalian species. 
1.11 Zebrafish – A Teleost Model for PGC-1α Research 
One promising organism for the study of PGC-1α in fish species is the zebrafish, a model 
organism highly valued due to its extensively annotated genome, relatively low caretaking costs 
and high reproductive output (Bailone et al., 2020; Suurväli et al., 2020). Collectively, these 
features position the zebrafish as an attractive model for high-throughput research and the 
creation of mutant lines serving as the perfect teleost analogue of the traditional mouse model. 
Additionally, zebrafish organs are highly reminiscent of human organs making them exceptional 
models organisms for biomedical and metabolic disease research (Befyaeva et al., 2010; 
Goldsmith & Jobin, 2012; Seth et al., 2013; Teame et al., 2019). Currently, few publications 
have examined the role of PGC-1α in zebrafish, however no consensus has been reached with 
regards to the actual role of this co-activator in teleost species. Some of the first investigations of 
PGC-1α disruption in zebrafish were accomplished by inserting human PGC-1α transcript 
downstream of the actc1b promoter, effectively creating a mutant zebrafish with localized PGC-
1α expression in muscle tissue. Consequently, this mutant experienced 8-fold increases in muscle 
PGC-1α expression and phenotypes that resembled previously described PGC-1α-overexpressed 
murine models; featuring ‘red meat’ muscle tissue, increased mitochondrial biogenesis, increased 
physical endurance, fibre-type switching and mitochondrial restructuring (Parisi et al., 2018). 
Although these results show that mammalian PGC-1α can elicit a phenotypic response in a 
teleost organism, it does not necessarily suggest that similar phenotypes occur in response to 
teleost PGC-1α overexpression. This is largely due to differences between teleost-mammalian 
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PGC-1α transcript (mentioned previously) and the relative expression of actc1b in comparison to 
endogenous PGC-1α. Additionally, both zebrafish and human PGC-1α transcripts were 
expressed simultaneously through different promoters, suggesting that both co-activators may be 
responsible for creating a hybrid phenotype.  
Another approach to identifying the role of PGC-1α in zebrafish featured the administration of 
anti-sense morpholino to effectively silence PGC-1α expression in larval zebrafish. Using 
specially redesigned siRNA, it is possible to temporally prevent the transcription of gene 
expression into function proteins. Recent work in our laboratory successfully created 2 
independent knockdowns to identify functional differences in larval zebrafish with decreased 
PGC-1α and PGC-1β expression. Fundamentally, this work suggested that zebrafish PGC-1α 
may be interacting with ERRα, but not NRF-1, strongly supporting the idea of evolutionary 
divergence in PGC-1α function between teleosts and mammals (Northam & LeMoine, 2019). 
Unfortunately, the research potential for zebrafish larvae is limited in comparison to the later life 
stages of juvenile and adult zebrafish due to the decoupling of exponential growth in early 
development and the presence of distinct tissues. Furthermore, zebrafish larvae are small and 
fragile, limiting the extent of performance and advanced physiological procedures that are 
required for determining both muscle and mitochondrial performance. Despite these differences, 
this investigation of PGC-1α activity in larval zebrafish provides sufficient evidence that the 
PGC-1α co-activator is divergent from that of mammalian species and suggests that further 






1.12 Thesis Objectives 
The main objective of my thesis is to examine the role of the metabolic co-activator PGC-1α in 
zebrafish to investigate underlying mechanisms of metabolic regulation in lower vertebrates. 
Currently, much of our understanding of cellular metabolism is based on mammalian models; 
with lower vertebrates obtaining very little attention. To accomplish this, I sought to create a 
zebrafish mutant line with modified PGC-1α expression to determine the molecular pathways 
and tissue-specific phenotypes promoted by this co-activator protein. In my 1st study, I 
successfully created this mutant zebrafish line by disrupting a newly discovered evolutionary 
conserved regulatory promoter region. This mutation vastly altered heart and muscle PGC-1α 
expression simultaneously, suggesting that this sequence holds a specialized function in muscle 
tissues. In addition, this mutation increased zebrafish O2 consumption in both isolated white 
muscle tissue fibres and whole juvenile zebrafish at rest, marking increased basal metabolism as 
a primary phenotype of this mutant line.  
In the 2nd study, I utilized the newly established PGC-1α mutant zebrafish line to determine if an 
increased basal metabolism would negatively impact the growth of mutant zebrafish during both 
larval and adult life stages. Newly hatched mutant larval zebrafish had a decreased heart rate 
with increased yolk sac content, suggesting decreased FA metabolism with decreased tissue 
growth at this early life stage. During the adult stage, mutant zebrafish displayed an increased 
ability to metabolize FAs but still experienced diminished growth even when supplemented with 
a high-fat diet, demonstrating that PGC-1α mutant zebrafish face impaired growth throughout 
their lifespan. In summary, the work presented here indicates that the regulatory networks 
coordinated by zebrafish PGC-1α are not entirely matched to those of mammalian PGC-1α, 
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however the regulatory region investigated may have conservative features worth further 


















Chapter 2: An evolutionary conserved regulatory sequence dictates 
PGC-1α expression in Zebrafish striated muscles  
Kurchaba N, Charette M and LeMoine CMR. In preparation for journal submission. 
2.1 Chapter Summary 
The peroxisome proliferator activated receptor gamma co-activator 1 alpha (PGC-1α) is central 
to the regulation of cellular and mitochondrial energy homeostasis in mammals, but its role in 
other vertebrates remains unclear. Indeed, previous work suggests extensive structural and 
functional divergence of PGC-1α in teleosts but this remains to be directly tested. Here, we 
describe the characterization of a heterozygous PGC-1α mutant zebrafish line created by 
CRISPR-Cas9 disruption of an evolutionary conserved regulation region of the PGC-1α 
proximal promoter. Using qPCR, we confirmed the disruption of PGC-1α gene expression in 
striated muscles, leading to a simultaneous 4-fold increase in mixed skeletal muscle PGC-1α 
mRNA levels and a contrasting 4-fold downregulation in cardiac muscle. In mixed skeletal 
muscle, most downstream effector genes were largely unaffected yet two mitochondrial lipid 
transporters, carnitine palmitoyltransferase 1 and 2, were strongly induced. Conversely, PGC-1α 
depression in cardiac muscle reduced the expression of several transcriptional regulators 
(estrogen related receptor alpha, nuclear respiratory factor 1 and PGC-1β) without altering 
metabolic gene expression. Using high resolution respirometry, we determined that white muscle 
exhibits increased oxidative capacity with little difference in mitochondrial function. Finally, 
using whole animal intermittent respirometry, we show that mutant fish exhibit a 2-fold higher 
basal metabolism than their wildtype counterparts. Altogether, this new model confirms a central 
but complex role for PGC-1α in mediating energy utilization in zebrafish and we propose its use 





The energetic demands of an animal are continuously adjusted to respond to environmental and 
physiological disturbances, requiring a dynamic equilibrium of energy acquisition and energy 
use. Under aerobic conditions, mitochondrial metabolism is central to an animal’s energy 
homeostasis. In the presence of oxygen, the organelle oxidizes fuel substrates to establish an 
electrochemical gradient and produce cellular energy. Thus, throughout an animal’s lifetime 
mitochondrial abundance and biochemical characteristics must be modulated to accommodate 
changes in bioenergetic demands (Chan, 2012; Woods, 2017). However, mitochondrial 
proliferation and maintenance is an intricate process that requires the synchronous regulation of 
hundreds of genes. This is further complicated by the shared responsibility of the nuclear and 
mitochondrial DNA for encoding all genes necessary for normal mitochondrial function (Francis 
et al., 2003; Jornayvaz & Shulman, 2010; Kang et al., 2007). At the transcriptional level, a suite 
of transcription factors and their coregulators collectively carry out this complex regulation and 
ensure metabolic homeostasis (Scarpulla, 2008, 2010).  
Particularly prominent among metabolic regulators, multiple members of the nuclear receptor 
family exert essential roles in mitochondrial control (Francis et al., 2003; Mazaira et al., 2018). 
Indeed, various members of the superfamily have been intensively studied in mammals due to 
their role in normal physiological function and various pathological states (e.g., cancer, heart 
failure, diabetes) (Robinson-Rechavi et al., 2003). In particular, the peroxisome proliferated 
activated receptor family (PPARα, PPARβ, and PPAR) plays an essential role in lipid 
metabolism, while the estrogen-related receptor a (ERRα) regulates both nuclear and 
mitochondrial genes essential to the organelle’s function (Ranhotra, 2015; Tyagi et al., 2011; 
Youssef & Badr, 2013). Beyond the nuclear receptor family, other important mitochondrial 
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regulators, such as the transcription factors Nuclear Respiratory Factor 1 (NRF-1) and NRF-2, 
facilitate mitochondrial biogenesis in mammalian cells (Wu et al., 1999). Although each of these 
transcription factors individually carry regulatory functions, their respective transcriptional 
activities are also tightly regulated by interactions with co-activator and co-repressor proteins. 
Central to this additional level of regulation, over the past decades the PPARγ Coactivator 1α 
(PGC-1α) has emerged as a master regulator of mammalian metabolic activity. As a co-activator, 
PGC-1α can bind to and regulate a multitude of TFs associated with metabolic genes (Ventura-
Clapier et al., 2008). In addition to the PPARs, Estrogen Related Receptor α (ERRα) and Nuclear 
Respiratory Factor 1 (NRF-1) serve as upstream activators for PGC-1α in mammals, controlling 
mitochondrial biogenesis, gluconeogenesis, β-oxidation, and muscle fiber remodeling (Finck & 
Kelly, 2006; Jornayvaz & Shulman, 2010; J. D. Lin, 2009). In mammalian systems, the 
coactivator drives many of the necessary mitochondrial adjustments in response to changes in 
energy demand, including cold-induced thermogenesis, fuel mobilization in fasting, or muscle 
adaptation to exercise (see Fernandez-Marcos and Auwerx, 2011 for review). The various stimuli 
responsible for PGC-1α induction apparently converge towards a handful of transcription factors. 
In particular, myocyte enhancer factor 2 (MEF2), forkhead box class-O (FoxO1) activating 
transcription factor 2 (ATF2) and cAMP response element-binding protein (CREB) all 
upregulate PGC-1α transcription by binding to upstream regulatory sites in its proximal promoter 
(Akimoto et al., 2005; Handschin et al., 2003; Herzig et al., 2001; J. Lin et al., 2002; Sajan et al., 
2018). 
Interestingly, while this ‘master controller’ is certainly central to metabolic plasticity in 
mammals, not all of these characteristics appear to be conserved by PGC-1α in other vertebrates. 
Indeed, the PGC-1α amino-acid sequence shows increased divergence amongst teleosts, 
25 
 
particularly with respect to the NRF-1 binding motif (LeMoine et al., 2010). Furthermore, 
dietary and temperature manipulations in goldfish showed alteration of mitochondrial function 
decoupled from PGC-1α but not the NRF-1 axis (LeMoine et al., 2008). Conversely, both 
PPARα and ERRα PGC-1α-binding motifs appear to be highly conserved throughout evolution, 
suggesting that these two TFs could still maintain interactions with PGC-1α and collectively act 
as important metabolic regulators in non-mammalian vertebrates (LeMoine et al., 2010).  
Recently, the use of reverse and forward genetics fostered the investigation of PGC-1α’s 
regulatory activity in non-mammals (Dumesic et al., 2019). Recently, morpholino silencing of 
PGC-1α in larval zebrafish suggested that metabolic cascades were negatively affected by PGC-
1α knockdown in early development (Northam & LeMoine, 2019). Thus, it appears that some 
PGC-1α-regulated roles remain partially conserved among vertebrates, but further experimental 
work is required to validate this argument. Unfortunately, the transient nature of morpholino 
knockdowns limited observations to early developmental time points and were insufficient to 
assess many of the potential roles of the co-activator in later life stages. Thus, given the 
complexity of PGC-1α regulation, we here developed a different approach to study endogenous 
function of PGC-1α in a teleost species throughout its lifetime. 
The use of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has 
provided an invaluable tool for investigating gene function in living model organisms. Such 
techniques allow for site-directed deletions occurring within the promoter region of target genes 
often leading to impaired function of the protein and cellular cascade imbalances resulting in a 
reprogramming of metabolic processes (Spiegel et al., 2019). Although the deletion of vital 
genes often leads to premature death, alternative approaches can be used to target regulatory 
regions (such as TF binding sites) to provide insight on endogenous regulatory mechanisms 
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(Babaei et al., 2019). The zebrafish has been used in a variety of CRISPR studies as a model 
organism due to its well-documented genome, high fecundity and external fertilization allowing 
for simplified CRISPR delivery (Cornet et al., 2018; Hruscha & Schmid, 2015). Furthermore, its 
use as a model organism is widespread in toxicology, comparative genetics, and biomedical 
research making it an ideal target to generate gain or loss of function models for broad use 
(Befyaeva et al., 2010; Goldsmith & Jobin, 2012; Gonzales & Joanna Yeh, 2014; Teame et al., 
2019). 
Thus, to investigate the role of PGC-1α in a lower vertebrate, we created a CRISPR zebrafish 
model targeting an evolutionary conserved region in a recently discovered regulatory region of 
the PGC-1α promoter (Dumesic et al., 2019). Our deletion disrupted putative TF binding sites, 
resulting in a 4-fold increase in PGC-1α mRNA expression in mixed skeletal muscle and 4-fold 
decrease in the heart. Our results indicate that PGC-1α expression potentially increases skeletal 
muscles’ fatty-acid (FA) transport through the carnitine palmitoyltransferase (CPT) axis and 
promotes increased mitochondrial capacity in white muscle. These in turn affect whole animal 
metabolism by effectively doubling their routine metabolic rate (RMR). With these properties, 
we propose that our mutant zebrafish line presents a valuable biomedical model for the 
investigation of various metabolic disorders and to further our understanding of PGC-1α as a 
metabolic coactivator in an established model organism representative of teleost species. 
2.3 Methods 
2.3.1 Caretaking 
Commercially obtained adult zebrafish were maintained and bred for several generations with 
ongoing introductions in our in-house colony. The fish were housed in an aquatic housing system 
(Aquaneering, San Diego, CA) maintained at 27°C with a 14:10hr light-dark cycle with two 
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feedings of Zeigler Adult Zebrafish Complete Diet and one feeding of Artemia naupii daily for 
the preparation of the F0 generation of mutant zebrafish. Embryos were obtained using breeding 
traps in communal holding tanks and collected shortly after the beginning of the light cycle. 
Embryos were washed with 0.05% bleach solution and rinsed with dechlorinated water twice 
prior to micro-injection. Injected embryos were kept at 28°C in E3 solution (5mM NaCl, 
0.17mM KCl, 0.33mM CaCl2, 0.33 mM MgSO4, 0.0006 mM methylene blue) for 5 days with 
daily medium changes before being moved into 300ml beakers filled with aged dechlorinated 
system water. Approximately 1/3 of the water was replaced daily following two feeding events; 
one with phase I/II larvae feed (<50/<200 microns) and another with Artermia naupii. On day 
21, the F0 zebrafish were moved into the aquatic housing system. All zebrafish were screened for 
mutations following the CRISPR HRM protocol described below. The F0 fish with considerable 
DNA deletions were then bred to produce the F1 generation. Care for the F1 generation of 
zebrafish was as described above. All procedures follow the guidelines of the Canadian Council 
of Animal Care and were approved by the Brandon University Animal Care Committee.   
2.3.2 CRISPR Design and Delivery 
The CRISPR gRNA was designed using the Benchling software to target potential regulatory 
sequences upstream of the PGC-1α promoter (Benchling, 2019). Two gRNAs with on-target and 
off-target scores above 60 were selected, synthesized and tested before opting for the guide with 
highest on-target mutation rate for the creation of the mutant line. The gRNA synthesis was 
performed using a GeneArt™ Precision gRNA Synthesis Kit following standard procedures with 
the use of custom template primers (Table S1). Prior to injection, the gRNA was mixed with 
GeneArt™ Platinum™ Cas 9 Nuclease in a 3:1 ratio with phenol red dye (20mg/µl) to visualize 
the site of injection. The first generation (F0) embryos received 100pl of injection mix via 
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microinjection using 1.0mm borosilicate glass micropipette needles into the yolk during the 
single cell stage with the use of picopump (PV830 Pneumatic Picometer, World Precision 
Instruments, Saratosa, FL) and micromanipulator (MM3301R, World Precision Instruments, 
Saratosa, FL) (Northam & LeMoine, 2019). We removed all embryos beyond the 2-cell stage 
post-injection to limit mosaicism. 
2.3.3 CRISPR Screening 
Fin tissue samples (adults) or whole embryos (larvae) were collected in order to identify 
potential mutant zebrafish. Prior to tissue collection, adult zebrafish were briefly exposed to 
100mg/L of tricaine solution until movement had ceased and gill movement had significantly 
slowed. Zebrafish were promptly removed from the tricaine solution and placed in a water filled 
petri plate for fin clipping before being returned to the aquatic system. All zebrafish were 
isolated and monitored for up to 1 week post-amputation to ensure adequate recovery before 
transfer to communal tanks in the same aquatic system. Fin clips were submerged in 10µl of 
NaOH and heated to 100°C for 10 minutes for crude DNA extraction as described previously 
(Samarut et al., 2016). Zebrafish embryos were humanely euthanized with 100mg/L of tricaine 
solution prior to DNA extraction following the same protocol as fin clippings.  
After DNA extraction, High Resolution Melt (HRM) analysis was used to examine the DNA 
melt curves of individual zebrafish (Qiagen, Hilden, Germany) (Samarut et al., 2016). A single 
primer set was generated using Primer3 to target a 200bp region surrounding the CRISPR site 
(Table S1, Untergasser et al., 2012). A standard concentration of DNA (50ug/µl) was used as 
suggested by the manufacturer's protocol. Using Qiagen RoterGene Q® software (V2.3.5, 
Qiagen, Hilden, Germany) we detected mutants using normalized melt curves by identifying 
deviations from wildtype zebrafish DNA profile (Figure S1). Multiple peaks and shifted melt 
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curves following normalization procedures allowed for the detection of mutant zebrafish and 
were used as diagnostics to establish the F1 generation. 
2.3.4 Sequencing 
Genomic DNA from 9 HRM-confirmed mutant zebrafish were selected for Sanger Sequencing to 
validate the position and identity of the CRISPR modified genomic DNA. PCR amplified DNA 
samples were cloned into plasmid vectors using NEB® PCR Cloning Kit (New England 
Biology, Whitby, Canada) following heat-shock absorption by competent E. coli plated on 
nutrient agar. Five individual colonies from each plate (45 colonies total) were subcultured in 
liquid media overnight prior to centrifugation to obtain a plasmid-rich liquid fraction and later 
purified using an EZ-10 Spin Column Plasmid DNA Minipreps Kit (Biobasic, Markham, 
Canada). Plasmid extracts were validated by gel electrophoresis and sent to Genome Quebec 
(Montréal, Canada) for Sanger sequencing. Sequence data was retrieved in FASTA format and 
aligned using Geneious Prime (Geneious, Auckland, New Zealand) to create consensus 
sequences. The consensus sequence was uploaded to rVista 2.0 to identify regulatory motifs 
using both mouse and human reference genomes (Loots & Ovcharenko, 2004). The region of 
interest was then used to retrieve similar sequences from representative vertebrate lineages, and 
aligned in Multalin (Corpet, 1988). 
2.3.5 RNA Extraction, Reverse Transcription and qPCR  
Twenty-four adult F1 PGC-1α mutant and wildtype zebrafish (12 and 12 respectively) were 
humanely sacrificed by concussion and severance of spinal cord, and dissected to obtain tissues 
(brain, gills, heart, liver, muscle, and gut) for RNA extraction. Samples consisted of 6 male and 6 
female control fish (300 ± 36 mg), and 9 male and 3 female mutant fish (308 ± 23 mg). All 
extractions were performed using an Animal Tissue Extraction Kit (Norgen, Thorold, Canada) in 
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accordance with the manufacturer’s protocol and each sample was inspected using a NP80 
Nanophotometer (Implen®, Munich, Germany) to validate RNA quantity and purity. A total of 
500ng of RNA was used to generate cDNA using the GoScript™ Reverse Transcription System 
(Promega, Madison, USA). The resulting cDNA was diluted prior to using Quantinova SYBR® 
Green PCR (Qiagen, Hilden, Germany) to assess the transcript levels of 14 genes (see Table S1). 
Target genes included transcriptional regulators (PPARα, ERRα, NRF-1), ETS components 
(COX IV), Krebs cycle enzyme (CS), lipid β-oxidation enzymes (HOAD, MCAD) and lipid 
transporters (FABP3, CPT-1, CPT-2).  Each primer set was checked for efficiency using 
standard curves ensuring efficiency values of 1.00 +/-0.20 (Northam & LeMoine, 2019). Gene 
expression values were calculated using the ΔΔCT method using the geometric mean of EF1a 
and Rpl1 as housekeeping genes (Ibarra et al., 2017). Statistical differences were detected using 
the Student’s t-test after confirming both normality and equal variance of the datasets. In 
instances where the data was not normally distributed, the data was normalized by log 
transformation and retested using the Student’s t-test. Genes that were normalized but failed to 
show equal variance (Heart PPARα, CS) were exclusively tested using the Welch t-test. 
2.3.6 High-Resolution Respirometry 
Twelve adult F1 zebrafish were sacrificed to individually assess mitochondrial function of red 
and white muscle. Sampling consisted of 6 mutants (3 males, 3 females; 480 ± 30mg) and 6 
wildtypes (4 males, 2 females; 446 ± 44 mg). High resolution respirometry was performed using 
the Oroboros O2K following the SUIT-002 (D006) protocol (Doerrier et al., 2018). Muscle 
fibers were quickly dissected and separated before being placed into ice-cold BIOPS buffer (10 
mM Ca-EGTA buffer, 0.1 µM calcium, 20 mM imidazole, 20 mM taurine, 50 mM K-MES, 0.5 
mM DTT, 6.56 mM MgCl2, 5.77 mM ATP, 15 mM phosphocreatine, pH 7.1) and cut into small 
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2mm x 2mm squares. Tissue fibers were permeabilized in saponin solution (5mg/ml) for 20 
minutes on ice with moderate shaking before being rinsed in BIOPS buffer for an additional 20 
minutes. Fiber bundles were blotted dry on filter paper prior to weighing and then directly 
inserted into the O2K chamber containing MiRO5 respiration medium (0.5mM EGTA, 60mM 
K+ Lactobionicate, 3mM MgCl2, 20mM Taurine, 10mM KH2PO4, 20mM HEPES, 110mM D-
Sucrose, adjusted to pH 7.1 with KOH; with addition of 1g/l BSA). Pressurized O2 provided 
sufficient oxygenation of the muscle fibers throughout the experiment. All values were 
background corrected using the DatLab Anaylsis Template. Statistical differences were 
calculated using Student’s t-test (Sigmaplot 14.0) between all specific flux values and flux 
control ratios (FCRs).  
2.3.7 RMR and MMR in Juvenile Zebrafish 
The resting metabolic rate (RMR) and maximum metabolic rates (MMR) of juvenile zebrafish 
were measured with intermittent flow-through respirometry. Sixteen zebrafish, consisting of 8 
mutants (40.2 ± 4.6 mg), 8 wildtypes (48.0 ± 4.2 mg), were individually chased for 5 minutes 
before being transferred to borosilicate tubes equipped with an oxygen sensor and two lines for 
water exchange. Measurements were conducted using AutoResp Software (Loligo Systems, 
Denmark) with a controlled flush loop (600s flush, 90s wait, 900s measurement). The 
measurement periods were further trimmed to 360s to focus on the linear segment of oxygen 
consumption. Data analysis was conducted with the use of RespR (v1.1.0.0, Harianto & Carey, 
2019) by using the linear auto_rate function to determine the MMR using the first loop and the 
RMR using the lowest 10th percentile of the subsequent loops. Statistical tests were performed 




2.4.1 CRISPR target 
Throughout this study we used an HRM approach to identify CRISPR mutated Zebrafish. To 
confirm the adequacy of this screening technique, we randomly selected several F1 fish showing 
a mutant phenotype on our HRM screen and sequenced the region of interest. The sequencing 
results confirmed the targeting of our CRISPR mutation to the PGC-1α proximal promoter. 
Moreover, we identified an extremely well conserved region of the PGC-1α promoter, as the site 
of several-overlapping mutations in CRISPR-F1 zebrafish (Figure 1). The most prevalent 
mutation consisted of a 7-bp deletion occurring near the 3’ end of the gRNA site. In addition, a 
smaller 4-bp and larger 13-bp deletion were also identified in several fish, in close proximity to 
the 7-bp deletion (Figure 3-1A). Using rVista 2.0, we identified in silico several putative 
regulatory regions within the overlapping regions of the DNA mutations including putative 
binding sites for MINI19/20, RUNX2, NFE2L1, and a highly conserved ATF/CREB response 
element. Comparing this region in various representative species indicates that the ATF/CREB 
response element is extremely well conserved in a majority of representative vertebrate species 
(Figure 3-1B). 
2.4.2 Gene Expression 
We sampled major tissues in adult fish and could only detect a significant impact of the mutation 
on PGC-1α mRNA levels in striated muscle tissues. In particular, CRISPR-mutants exhibited an 
overall 4-fold increase in mixed skeletal muscle and a contrasting 4-fold decrease in cardiac 
muscle (Figure 2-2A). To investigate the downstream effects of PGC-1α dysregulation in these 
two tissues, we examined multiple genes associated with metabolism and regulatory pathways. 
In skeletal muscle, none of the transcription factors assessed were significantly affected, though 
33 
 
PPARα levels were marginally increased. In contrast, we identified a net 4-fold increase in gene 
expression of CPT-1, paralleling the increase in PGC-1α levels, and a 29-fold change in CPT-2 
mRNA levels (Figure 2-2B). All other effectors assessed (CS, COX IV, HOAD, MCAD, 
FABP3) seemed unaffected by PGC-1α overexpression in mixed skeletal muscle. In contrast, the 
reduction of PGC-1α transcript levels in cardiac muscle was accompanied by 50-70% decrease in 
gene expression of three central metabolic regulators: ERRα, NRF-1, and PGC-1β (Figure 2-2C). 
While not significant, a trend for downregulation of CS and COX IV was also apparently in 
cardiac muscles, while fatty acid metabolism enzymes were virtually identical in mutant and 
wildtype fish.  
2.4.3 High-Resolution Respirometry 
In order to measure mitochondrial activity in response to individual substrates, we assessed 
potential differences in red and white muscle mitochondrial physiology by measuring oxygen 
flux between permeabilized muscle fiber types isolated from wildtype and mutant fish. Overall, 
mitochondrial capacity per tissue weight amongst control fish was higher in red muscle, with an 
average doubled capacity for fatty acids respiratory flux, Complex I-III activities and for total 
electron transport chain capacity. As individual differences in mitochondrial efficiencies could 
be obscured by total fluxes and sample preparations, we also compared flux corrected ratios 
(FCRs) between muscle types. The FCRs of red and white muscles showed similar oxidative 
profiles suggesting that mitochondrial populations in the two tissues have similar functional 
characteristics in wildtype fish. In red muscle, although there seemed to be a trend for higher 
fluxes in mutant fish, none of the substrate/inhibitors additions significantly affected respiratory 
fluxes whether corrected for tissue weight or maximal flux (Figure 3A). In contrast, in the white 
muscle of mutant fish, fatty acid oxidation was marginally increased (p= 0.09), and there was a 
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30-40% significant increase in flux though Complex I-III per tissue weight (Figure 2-3B). In 
addition, mass corrected total electron transport chain capacity was 30% higher in mutant fish 
(Figure 2-3B), along with a parallel 25% increase in flux through Complex IV (data not shown). 
Once again, when corrected for maximal flux rates, the FCRs were identical in permeabilized 
white muscle of both mutant and wild type fish.  
 
Figure 2-1: The CRISPR-Cas9 mutation occurred in an evolutionarily conserved region hosting multiple regulatory 
elements. A) Sanger sequencing alignment of individual mutants with the PGC-1α reference sequence, with the 0-position 
indicating the beginning of the start codon. Three different mutations were identified amongst mutant zebrafish with each 
mutation disrupting the conserved ATF/CREB response element (TGCCGTCA). B) Comparative alignment of the deleted region 
shows a high degree of sequence conservation between vertebrate species. Accession numbers for the included genetic 
transcripts: 1 - XM_017357140.2, 2 - XM_006629820.2, 3 - XM_007889043.1, 4 - XM_005997866.2, 5 - XM_029590174.1, 6 - 
XM_034770966.1, 7 - XM_028743340, 10 - XM_004681371.2, 8 - XM_025205580.1, 9 - XM_027795074, 10 - 




Figure 2-2: The CRISPR-Cas9 mutation altered PGC-1α expression in striated muscle tissues. A) PGC-1α expression 
across multiple tissues in both mutant and wildtype individuals. Sample sizes varied between tissue types (Muscle = 6, Heart = 
5x2, Liver = 4, Intestine = 4, Gills = 3). PGC-1α expression was upregulated in muscle tissue 4-fold (p = 0.009) and 
downregulated in heart tissue 4-fold (p = 0.012). B) Increased PGC-1α expression in muscle tissue greatly increased CPT-1 
(0.023) and CPT-2 (p = 0.009) gene expression 4-fold and 29-fold respectively. C) Decreased PGC-1α expression in cardiac 
tissue reduced ERRα (p = 0.011), NRF-1 (p = 0.016) and PGC-1β (p = 0.045) expression. Fold-increases were calculated by 






Figure 2-3: Mutant zebrafish maintained similar oxygen fluxes in permeabilized red muscle fibres, with increased oxygen 
fluxes in permeabilized white muscle fibres. A) Mutant zebrafish displayed similar flux values in red muscle fibres during each 
step of the SUIT-002-005 protocol. B) Mutant zebrafish maintained higher specific flux values immediately once placed into the 
O2K (p = 0.038), and when FA and CI pathways were activated following PMG addition (p = 0.014). Further activation of the 
mitochondria following S addition and the saturation of the FA, CI and CII pathways produced greater specific flux differences 
between mutant and wildtype zebrafish (p = 0.005), with GpDH addition also maintaining differences in specific flux (p = 0.025). 
M – Malate, Oct – Octynolcarnitine, PMG – Pyruvate-Malate-Glutamate, GpDH - Glycerol-3-phosphate dehydrogenase, CCCP - 




2.4.4 Whole Animal Respirometry 
Given the impact of the PGC-1α mutation on skeletal muscle oxidative phenotype, we explored 
the impact our genetic manipulation could have on whole organismal metabolism. We first 
assessed a proxy of mass-specific maximal metabolic rate (MMR) by performing a 5-minute 
chase of the fish prior to oxygen consumption rate measurement. Overall, there was no 
observable difference in oxygen consumption between mutants and wildtype fish under these 
conditions. In contrast, when we measured mass-specific resting metabolic rate (RMR) 
overnight, mutant fish exhibited an oxygen consumption rate two-fold higher than their wildtype 
counterparts (Figure 2-3). Consequently, mutant fish exhibited an approximate 7% reduction in 
estimated aerobic scope (MMR-RMR), but this metric was not deemed statistically significant.
 
Figure 2-4: Mutant juvenile zebrafish maintain a higher resting metabolism in comparison to wildtype zebrafish. The 
maximum metabolic rate held near identical O2 consumption rates between mutant and wildtype zebrafish, however mutant 





In mammals, the PGC-1 family of coactivators is of prime importance to the regulation of a 
plethora of metabolic pathways. In particular, the founding member of the family, PGC-1α, is 
ubiquitously expressed in mammals and plays a predominant role in muscle homeostasis in both 
health and disease. Until recently, the role of this co-activator in other biomedical model 
organisms such as the zebrafish remained elusive, hindering the use of this animal model in 
comparative metabolic and biomedical research. In the current study, we show that mutations in 
a highly conserved region of the PGC-1α promoter disrupts muscle-specific expression of this 
energetic co-activator. More specifically, this mutation drives skeletal and cardiac muscle PGC-
1α gene transcription in opposite directions resulting in broad metabolic implications at the 
genetic, mitochondrial and whole organismal level.  
2.5.1 A Conserved Regulatory Sequence Controls PGC-1α Expression in Striated Muscle 
In order to modulate PGC-1α gene expression we opted to target the zebrafish PGC-1α proximal 
promoter, a region characterized by several regulatory sites in mammals (see Fernandez-Marcos 
and Auwerx, 2011). This region contains notable response elements for the human PGC-1α start 
codon such as MEF2 (-1,400 bp), FOXO1 (-500bp) and ATF/CREB (-130 bp) (Akimoto et al., 
2005; Handschin et al., 2003; Sajan et al., 2018; Zhao et al., 1999). Through our CRISPR design, 
we specifically targeted a site immediately (-20bp) upstream of the PGC-1α start codon. Upon 
further in silico exploration of this area, we identified several putative transcription factor 
binding sites, including motifs for ATF/CREB/TCF and MINI19B/20B. From a regulatory 
perspective, the Muscle Initiator Sequences (MINI19B/20B) is interesting though relatively 
undescribed, but may serve as a repressor in muscles since its motif is exclusive to genes 
expressed in muscle tissue (Frith et al., 2004) and should be certainly explored further. The other 
predominant regulatory site, the putative ATF/CREB/TCF motif has an extensive repertoire of 
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roles devoted to metabolic regulation. Indeed, these motifs are highly abundant in eukaryotic 
promoters with ATF/CREB postulated to regulate expression of approximately 25% of all genes 
(Moore et al., 2016), playing a critical role in the regulation of cellular growth and metabolism 
(Shanware et al., 2010; Wen et al., 2010). More specifically, the CREBP-mediated activation of 
the mammalian cAMP regulatory cascade manages injury, regeneration, and intense exercise 
related pathways in muscle tissue (Berdeaux & Hutchins, 2019; Egan et al., 2010; Popov et al., 
2019; Stewart et al., 2011; Widegren et al., 1998). Additionally, this pathway serves as a central 
regulatory pathway of PGC-1α expression in brain and liver (Handschin et al., 2003; Herzig et 
al., 2001; Lee et al., 2018; Liu et al., 2014). The CREBP pathway is also an important mediator 
of muscle homeostasis in zebrafish, as CREBP-targeted knockouts negatively impact muscle 
structure and function (Fauquier et al., 2018). In addition, the TCF regulatory element disrupted 
by our mutation is also closely linked to the CREB pathway with evidence suggesting that TCF 
may act as a co-repressor when present with CREB (Barker et al., 1999). Interestingly, the PGC-
1α CRISPR-induced mutations resulted in differential expression of the co-activator in opposite 
direction in the heart and mixed skeletal muscle of zebrafish, with no impact on other tissues (see 
below). Certainly, while some transcription factors have ubiquitous effects across tissue types, 
others may be more restricted to certain tissues allowing inter-tissue variability in regulatory 
pathways (Qian et al., 2005; Sonawane et al., 2017; Vaquerizas et al., 2009). Furthermore, recent 
work suggests that a region in the 5’-URF is responsible for muscle PGC-1α repression in fish 
(Dumesic et al., 2019). Here we contend that this repression sequence can be further focused to a 
narrower region directly targeted by our CRISPR mutation. We propose that this promoter region 
may disrupt the transcriptional pathways of striated muscles as evidenced by the opposing effects 
of the mutation in cardiac and skeletal muscles.  
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2.5.2 Gene Expression  
In order to gain insight on the effects of PGC-1α dysregulation in striated muscles we explored  
the expression levels of three important regulatory factors (PPAR, NRF-1 and ERRα) that 
regulate key metabolic genes in conjunction with PGC-1α (Huss et al., 2002; Vega et al., 2000; 
Wu et al., 1999). Based on their respective roles and previous work in zebrafish (Northam & 
LeMoine, 2019), we hypothesized that levels for these regulators would parallel changes in 
PGC-1α expression. Surprisingly, transcript levels of NRF-1/ERRα, but not PPARα, were 
downregulated in the heart due to PGC-1α suppression. In contrast, although PPARα levels 
seemed elevated, no significant changes amongst transcription factor expression were detected in 
skeletal muscle tissues overexpressing PGC-1α (Figure 2B). While the overall roles of these 
transcription factors are thought to be conserved throughout vertebrates, their respective 
interactions with PGC-1α have been questioned. Indeed, while the PPAR/ERRα binding site of 
PGC-1α is highly conserved in vertebrates, the putative NRF-1 binding motif is highly divergent 
in teleosts (LeMoine et al., 2010; Parisi et al., 2018). Considering that at least some of the 
interactions of PGC-1α with PPAR, NRF-1 or ERRα involves positive autoregulatory loops, the 
patterns we see here suggest a dissociation between PGC-1α and its binding partners. 
Interestingly, PGC-1β is strongly downregulated in the heart suggesting a regulatory relationship 
between the two coactivators. Indeed, previous observations in whole zebrafish larvae have 
demonstrated that PGC-1α knockdown has marginal effects on PGC-1β levels in whole zebrafish 
larvae (Northam & LeMoine, 2019). Considering that PGC-1β has been suggested as a 
modulator of some NRF-1 cascades in several fish models (Katharina Bremer et al., 2012; 
LeMoine et al., 2008; Northam & LeMoine, 2019), our results suggest that it may be the 
subsequential knockdown of PGC-1β that causes downregulation of some of the transcription 
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factors observed in cardiac muscle. Furthermore, given the stark contrast between the 
transcriptional patterns of the two muscle types, it is also very likely that these regulatory 
relationships are tissue specific. It should be noted that there have been instances of a 
dissociation of the mammalian PGC-1α/NRF-1 axis in previous knockout experiments in 
rodents. For example, muscle specific PGC-1α knockout mice failed to affect NRF-1 but resulted 
in a 50% reduction of ERRα expression and mitochondrial abundance (Handschin et al., 2007). 
Thus, while genetic PGC-1α models offer insight in the function of the coactivator, it is clear that 
some variability exists presumably due to the variety of approaches (e.g., whole body vs. single 
tissue knock-in/out), and animal model employed. However, we still propose our mutant line as a 
promising starting point to evaluate these regulatory cascades in zebrafish. 
To further probe PGC-1α function, we assessed the expression of putative targets of the NRF-
1/PPARs/ERRα pathways. In skeletal muscle, the only genes affected were the mitochondrial 
lipid transporters CPT-1 and 2. These two transporters are thought to be regulated through a 
PGC-1α/PPARα axis in mammals (Huss et al., 2004), though interestingly MCAD and HOAD 
are also regulated via that pathway but seem unaffected by PGC-1α overexpression. However, it 
is important to note that in zebrafish, as in most teleosts, several genes including the PPARs have 
experienced additional duplication events, leading to the presence of several isoforms  (Den 
Broeder et al., 2015). Thus, it is likely that some redundancy exists in these regulatory pathways 
and it is possible that FAO associated enzymes in skeletal muscle are regulated via parallel 
pathways, such as another PPAR member or via other nuclear hormone receptors (e.g., ERRα, 
(Villena & Kralli, 2008). Furthermore, it is also possible that the PGC-1α promoter controlling 
CPT-1/2 expression is of prime importance under basal condition in muscle, given the lack of 
response elicited by the remaining target genes. 
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In cardiac muscle, none of the effector transcripts were significantly affected. Although 
treatment variability was high amongst certain genes, increasing our sample size failed to reduce 
it, thus we are confident in the overall pattern presented here. Given the overall lack of response 
in cardiac metabolic gene expression, it seems that both PGC-1α and β have a lesser influence on 
the metabolic phenotype of this tissue under basal conditions. It should be noted that due to 
reduced tissue and animal availability, we only were able to assess mixed skeletal muscles in this 
study, likely obscuring some of the shifts seen in gene expression. However, current efforts to 
generate stable homozygous mutant lines should further clarify some of these regulatory 
relationships and the differences between the two types of skeletal muscles. 
2.5.3 High-Resolution Respirometry  
To fully investigate the effects of PGC-1α upregulation on mitochondrial function, we examined 
aspects of red and white muscle oxidative capacity using high-resolution respirometry in adult 
fish. This enabled us to assess mitochondrial activity by controlled sequential activation and 
deactivation of the various mitochondrial components (Doerrier et al., 2018). In particular, we 
aimed to determine putative changes in FAO capacity in mutant zebrafish as suggested by the 
significant upregulation of FAO transporters gene expression (see above). For our analysis, we 
compared raw oxygen consumption as an estimate of overall mitochondrial density and 
calculated FCRs to provide insight on mitochondrial performance within each tissue and 
genotype (Porter & Wall, 2012). As expected, the highly oxidative red muscle exhibited much 
higher respiratory rates than white muscle. In zebrafish, red muscle tissue lies as a superficial 
lateral thin band of muscle and is responsible for slow-twitch movements for prolonged activity 
including general locomotion and feeding, while the majority of the axial musculature is made 
up of white muscle used for spontaneous movements such as burst swimming (Dou et al., 2008; 
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Luna et al., 2015; van Raamsdonk et al., 1982). While the difference was not as dramatic as 
described before for other teleosts, the overall pattern is comparable to previous investigation in 
zebrafish (Moyes et al., 1989; Teulier et al., 2018).  
In white muscle, we observed a pronounced increase in raw oxygen flux across multiple 
substrates with minimal differences between intrinsic FCRs. Consequently, it appears that PGC-
1α mutants demonstrate a higher white muscle oxidative capacity with overall little intrinsic 
differences in mitochondrial function. While the molecular regulatory cascade responsible for 
these changes is largely unclear at this point, upregulation of PGC-1α in skeletal muscle clearly 
provoked mitochondrial proliferation in white muscle, a phenotype reminiscent of mammalian 
models of PGC-1α muscle overexpression (Geng et al., 2010; Huss et al., 2004). Red muscle did 
not exhibit much response but given the typically high mitochondrial density in this tissue, up to 
40% per volume, there may be little room for further increases in organelle density (Battersby & 
Moyes, 1998; Suarez, 1996).  
In mutant fish, neither of the skeletal muscles showed differences in maximal FAO capacity 
despite the large upregulation of CPT-1 and 2. However, octanoylcarnitine, the FA substrate 
used in our assay, bypasses CPT-1 and thus is more indicative of the capacity to oxidize fatty 
acids rather than the process of transporting them into the organelle (Ojuka et al., 2016). 
Nonetheless, we observed a doubling in raw oxygen flux in response to low concentrations of 
malate and ADP prior to the addition of any substrates. Since malate is essential for -oxidation 
to proceed when no other electron donators are present (Gnaiger, 2014), we propose that 
endogenous FA may have been more readily mobilized in mutant zebrafish white muscle 
potentially resulting in an increased metabolic output with little changes in individual 
mitochondrial performance.  
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2.5.4 Whole Animal Respirometry 
Considering that white muscle constitutes approximately 90% of total muscle mass (Kiessling et 
al., 2006; Rovira et al., 2017), which itself likely accounts for large proportion of total body 
mass, we hypothesized that a 20% increase in white muscle mitochondrial activity would have a 
nominal impact on whole organism metabolism. Thus, we assessed if mutant zebrafish display a 
heightened metabolic rate as a result of our mutation. We measured metabolic activity at 
minimum and maximum points of activity to assess the metabolic scope of juvenile fish 
(Claireaux & Lefrançois, 2007). To evaluate routine O2 consumption, our aim was to observe 
individual zebrafish overnight to obtain the lowest basal rate possible (Chabot, Steffensen, et al., 
2016; Drown et al., 2020).  During this period mutant PGC-1α zebrafish maintained an average 
two-fold increase in metabolic output, indicating that baseline metabolism was forcibly increased 
during routine activity. Conversely, we chased the fish to exhaustion to evaluate their maximum 
metabolic rate (MMR), while we recognize that this technique presents caveats (Andersson et al., 
2020), it remains a useful proxy to evaluate MMR in our model (Little et al., 2020). Further, 
while RMR is typically relatively consistent within species, MMRs can vary between individuals 
due to its forced activation of muscle tissue (Norin & Clark, 2016; Weibel & Hoppeler, 2005). 
As such, we expected that mutant PGC-1α zebrafish would exhibit an increased metabolic rate in 
comparison to their wildtype counterparts to mimic the RMR comparison. Despite differences in 
mean MMRs across both treatments, we were unable to identify an increase in maximal 
performance due to the induced PGC-1α mutation. In turn, this would suggest that mutant PGC-
1α fish exhibit a relatively smaller aerobic scope, further making them an interesting model to 
assess the impact of aerobic scope on whole animal performance. However, while we present 
some interesting observations, it is clear that many other performance variables should be 
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assessed in further detail, such as swimming capacity and maximal active metabolic rate during 
sustained swimming.  
2.6 Conclusion 
Our findings suggest that a mutation of an evolutionary conserved regulatory sequence was 
sufficient to upregulate PGC-1α expression in skeletal muscle resulting in an increased resting 
metabolism. At the tissue level, this translated into an elevated mitochondrial capacity and fatty-
acid mobilization in adult zebrafish muscle. As differences in muscle tissues can have vast 
impacts on the overall organismal health, we propose that our mutant zebrafish line has the 
potential to serve as a unique biomedical model for the study of metabolic disorders, particularly 
those involving lipid metabolism. Furthermore, we will certainly be able to capitalize on this 
model from a comparative perspective to elucidate the significance and evolution of these 











Chapter 3: Altered PGC-1α expression in Zebrafish limits growth 
irrespective of nutrient consumption 
Kurchaba N, Duncan E, LeMoine CMR. In preparation for journal submission. 
3.1 Chapter Summary 
Animals must carefully budget energy derived from nutrients in order to survive and grow. This 
process requires the coordination of metabolic pathways with respect to environmental and 
internal physiological conditions, however the underlying mechanisms controlling energy 
allocation for growth remain complex and relatively unexplored. The metabolic co-activator 
PGC-1α plays a central role in regulating growth in response to caloric reduction and abundance 
in mammalian species, however few reports have examined its role in other vertebrates. In this 
study, we examined the role of PGC-1α in zebrafish growth using a previously established PGC-
1α mutant zebrafish line with increased expression in muscle tissue and decreased expression in 
cardiac tissue. We observed mutant zebrafish larvae during early development (4-6 days post 
fertilization) and observed decreased heart rate post-hatching and a reduction in yolk lipid 
utilization amongst mutants, indicating that PGC-1α may serve as an important mediator for 
growth and fatty acid (FA) metabolism during early development. Conversely, adult mutant 
zebrafish maintained a higher metabolic rate following a high-fat meal during the specific 
dynamic action period. This increased metabolic rate likely delayed growth in adult zebrafish 
exposed to either a standard or high-fat diet over a 3-week period, with male zebrafish 
experiencing less growth than females. Upon viewing the FA profiles of adult male zebrafish, we 
identified a mutant-specific deficiency of Dihomo-gamma-Linolenic Acid, a FA responsible for 
reducing mitochondrial proton leakage. These results suggest that PGC-1α plays an important 
role in FA metabolism in zebrafish with important consequences for both larval and adult 




The overall health of an animal is heavily dependant on the nutritional diet consumed during its 
lifespan. In nature, animals rely on the environmental abundance of nutrients to fuel ongoing 
bioenergetic processes in addition to maintaining pre-existing tissue mass. Fluctuations in 
environmental conditions often affect nutrient availability, requiring animals to modulate their 
metabolism constantly to survive. For example, during extreme fasting periods or starvation, 
animals may restrict their movement or metabolic processes (Heilbronn & Ravussin, 2003; 
Novak et al., 2005). Conversely, when nutrients are consumed in excess, animals can carefully 
reinvest their energetic surplus into future fuel reserves (fat) or initiate growth by building new 
tissue mass (Sibly et al., 2015; West et al., 2001). However, prolonged overfeeding combined 
with a sedimentary lifestyle can be detrimental to an animal’s well-being, as fat accumulation 
can lead to metabolic dysfunction (for example: obesity, diabetes and stroke) (Kern & 
Mitmesser, 2018; Saklayen, 2018). As such, healthy growth requires a careful balance between 
immediate energetic demands and investment into additional tissue mass. 
In mammals, PGC-1α (Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 α) 
serves as a mediator between energy reserves and energetic demands. With the use of genetic 
mouse models, the PGC-1α protein has been described as a key protein involved in many 
metabolic processes, such as thermogenesis, mitochondrial biogenesis, fatty acid oxidation 
(FAO), glucose metabolism and muscle fibre-type switching (Huss et al., 2002; Lin et al., 2002; 
Puigserver et al., 1998; Wang et al., 2003; Wende et al., 2007). Although many of these 
processes are vital to an organism’s survival regardless of environmental status, current evidence 
suggests that PGC-1α regulates all these processes in response to energetic cues. Indeed, caloric 
restriction with forced PGC-1α expression shifts mitochondrial fuel preference to endogenous 
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lipid reserves with enhanced mitochondrial respiration. Additionally, forced PGC-1α expression 
in cell cultures impairs growth despite increases in energetic output, suggesting that much of this 
energy is dissipated elsewhere (Miller et al., 2019; Villena, 2015).  
The role of PGC-1α in mammalian models (mouse and human cells) has been documented 
extensively in biomedical literature, however very few studies have examined the role of PGC-
1α in other vertebrates. Many of these other vertebrates (amphibians, reptiles and fish) are 
ectothermic and lack the capacity for thermogenesis, resulting in reduced metabolic activity 
during sub-optimal temperatures to maintain thermal homeostasis (Else & Hulbert, 1981; 
Seebacher et al., 2009). Examination of PGC-1α transcripts across vertebrate phylogeny 
demonstrates that the PGC-1α protein structure is preserved within vertebrates, however several 
teleost species contain various insertions in some of the transcription factor binding motifs 
(LeMoine et al., 2010). Interestingly, research examining the role of PGC-1α in various fish 
species suggests that teleost PGC-1α carries both similar and divergent roles from those 
previously described in mammals (Bremer et al., 2016; Bremer et al., 2012; Northam & 
LeMoine, 2019; Parisi et al., 2018). 
Recently, we established a stable PGC-1α-mutant zebrafish line in hopes to further understand 
the role of PGC-1α in a teleost species. Our mutant zebrafish line contains a deletion in a 
recently discovered regulatory region found upstream of the PGC-1α promoter, resulting in a 
simultaneous increase in white muscle PGC-1α expression and down-regulation of heart PGC-1α 
expression. Reminiscent of previous mammalian studies, we found that zebrafish with forced 
muscular PGC-1α expression increased the expression of fatty acid (FA) transporter proteins 
CPT-1/2 alongside increased whole-body metabolic rate and higher maximal O2 consumption in 
permeabilized white muscle fibers. However, we observed no differences in the expression of  
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transcription factors (ERRα, NRF-1, PPAR-α), mitochondrial enzymes (CS, COX V) or FAO 
enzymes (HOAD, MCAD) that are known targets of PGC-1α regulation in mammals. Clearly, 
the PGC-1α protein remains elusive and requires further investigation to fully understand the 
consequences of metabolic dysregulation. 
In this study, we examined the connection between increased metabolic rate and increased FAO 
with respect to growth using our PGC-1α zebrafish model. Our investigation began by 
examining yolk-limited FA metabolism and heart rate during early development of zebrafish 
larvae and identified decreased lipid metabolism in addition to decreased overall heartrate. 
During the adult stage, zebrafish fed a high-fat meal demonstrated a 2-fold increase in overall O2 
consumption during the post-prandial period, with an extended SDA (Specific Dynamic Action) 
window suggesting heightened fatty acid (FA) metabolism. In addition, wildtype and mutant 
zebrafish were fed standard or Artemia-supplemented (high-fat) diets for 3 weeks to monitor the 
effect of diet and genotype on the growth of individual adult zebrafish, and the metabolite profile 
of their muscle tissues. Interestingly, mutant zebrafish exhibited impaired growth, even with high 
caloric supplementation. Finally, targeted metabolomic analyses revealed that male mutant 
zebrafish fed a high fat diet had reduced levels of Dihomo-Gamma-Linolenic Acid (DGLA), a 
FA that reduces proton leak in the mitochondria. With our findings, we propose that our mutant 




All zebrafish were derived from an initial stock of zebrafish that were commercially obtained 
and housed in our aquatic Aquaneering system (Aquaneering, San Diego, USA) maintained at 
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27°C with a 14:10hr light-dark cycle. Stock zebrafish were bred and genetically altered by 
CRISPR to produce F0 subsequently F1 PGC-1α-dysregulated mutant zebrafish as described 
previously (see Chapter 2). Following breeding all embryos were rinsed in 0.05% bleach solution 
before being rinsed twice with dechlorinated water. Larval zebrafish were transferred to E3 
medium (5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33 mM MgSO4, 0.0006 mM methylene 
blue) for 5 days with daily solution changes before being transferred to 300ml beakers containing 
aged dechlorinated water. Zebrafish were fed twice daily with phase I/II larval feed (<50/<200 
microns) until 21 days post-fertilization (dpf), with daily replacement of 1/3 total water volume. 
Zebrafish were transferred into a recirculating system until adulthood. Water quality in the 
recirculating system was monitored daily to ensure optimal holding conditions during the 
experiment. Zebrafish were fed Zeigler Complete Diet pellets (Zeigler, Gardner, USA) twice 
daily and freshly hatched Artemia naupii (OceanStar, Snowville, USA) each morning. Both 
wildtype and mutant F1 zebrafish were raised identically as littermates, and only separated at 
adulthood upon genotype determination. All procedures follow standards of the Canadian 
Council for Animal Care and were approved by the Brandon University Animal Care 
Committee. 
All F1 mutant zebrafish were genotyped to validate their genetic identity. We followed a 
previously described High Resolution Melt (HRM) protocol that allows for the quick detection 
of mutants by observing the melting temperature of 200bp segments surrounding the CRISPR 
target site (see Chapter 2). Individual zebrafish were removed from the tank and exposed to 
tricaine solution (100mg/L) until movement ceased, then transferred to a small petri plate for the 
collection of a small sample of the caudal fin. Subsequently, zebrafish were returned to the 
recirculating system and kept isolated for 1 week to ensure optimal recovery. Each caudal fin 
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clipping was subjected to crude DNA extraction for genotyping using High Resolution Melt 
(HRM) analysis using a Type-It HRM PCR kit (Qiagen, Aarhus, Denmark) (Samarut et al., 
2016). Upon analysis of the HRM diagnostic, fish were separated into two groups based on their 
genotype, termed ‘Wildtype’ and ‘Mutant’ prior to beginning any of the after mentioned 
experiments. 
3.3.2 Monitoring Larval Heartrate 
The heartrate of larval zebrafish was measured over a 3-day period (4– 6dpf) to mirror the 
developmental timepoints of the lipid content assay. In order to minimize temperature 
fluctuations during the experiment, we set up a temperature-controlled arena consisting of water 
pump, custom glass arena, and a water bath maintained at 28C°. This arena was mounted below 
a microscope fitted with an AmScope MU300 camera (AmScope, Irvine, USA) to capture video 
recordings of individual zebrafish larvae using AmScope software (v3.70). Inside the arena, we 
used aquarium grade silicone and plastic dividers to create two sections inside the arena; one 
containing 50mg/L of tricaine-E3 solution, a concentration deemed to have minimal 
consequences on attenuating heart rate in larval zebrafish (Northam & LeMoine, 2019; Tzaneva 
& Perry, 2016), and another with E3 solution. Prior to assessing the heart rate of individual 
zebrafish, we placed each zebrafish in the tricaine-E3 solution for three minutes to attenuate 
movement. After the three-minute period, zebrafish larvae were transferred to the E3 medium 
and orientated for the recording of zebrafish heartrate. All videos were recorded at 24fps using 
the lowest video quality to maintain visual smoothness for accurate heart rate measurements. 
Between each measurement period, zebrafish were thoroughly washed in E3 solution to prevent 
excess exposure to tricaine. At the end of the experiment, all zebrafish were collected for crude 
DNA extraction and HRM genotyping. 
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3.3.3 Lipid Content in Zebrafish Larvae  
To evaluate yolk lipid content, zebrafish larvae (3dpf) were exposed to Nile Red solution 
(5ng/ml) for 8hrs as described previously (Jones et al., 2008; Miyares et al., 2014). For three 
subsequent days, we monitored yolk fluorescence and area using an MVX10 microscope 
(Olympus, Waltham, USA) using the included Green Fluorescent Protein (GFP) filter. Larval 
zebrafish were anaesthetized with cold 50mg/ml tricaine solution prior to photographing and 
were returned to fresh E3 medium afterwards. Lateral images of zebrafish larvae were analyzed 
using ImageJ software to calculate the area and relative fluorescence of the yolk (Schneider et 
al., 2012). All zebrafish larvae used for yolk measurements were isolated throughout the entire 
experiment to allow for individual-level analysis. The experiment was terminated on 6dpf and 
zebrafish larvae were sacrificed for whole-body DNA extraction and HRM genotyping.   
3.3.4 Post-Prandial Metabolic Scope 
Post-prandial metabolic state of adult wildtype and mutant zebrafish was assessed over a 10-hour 
period using intermittent respirometry. Both wildtype and mutant zebrafish were starved 24h 
prior to the beginning of the experiment where they received 300mg of hatched Artemia naupii 
as a morning meal in their holding tank with the recirculation system turned off for a 15-minute 
period. Fish were then swiftly transferred to a Loligo® Systems swim tunnel respirometer 
(Loligo Systems, Viborg, Denmark), fitted with a 170mL chamber and 2 oxygen dipping probes 
to measure oxygen consumption in the chamber and a background measurement from the 
surrounding water. The swim tunnel and oxygen probe were configured using AutoResp 2.0 
software (Loligo Systems) and programmed according to a 1-hour loop (2910s flush, 90s wait, 
600s measure) to collect hourly measurements. During the measurement period, the internal 
swim tunnel motor was used at minimal speed to maintain water recirculation but with no 
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adverse effect on the fish during the experiment. The water in the system was kept at 26°C with a 
submersible heater, and water quality was maintained with a standard aquarium water filter. The 
swim tunnel and the surrounding water was manually cleaned prior to start of each experiment 
and 1/3 of the swim tunnel water was replaced with fresh dechlorinated water. After 23 hours in 
the respirometer, the fish was removed from the chamber and sacrificed to obtain weight and 
length measurements. The metabolic activity of the zebrafish was analysed using RespR 
(v1.1.0.0), to allow subtraction of background measurements and rate conversions as previously 
described (Harianto & Carey, 2019; Chapter 2). 
3.3.5 Prolonged High-Fat Dietary Exposure 
The diet of both wildtype and mutant zebrafish was manipulated over a 3-week period to assess 
the effects of a high-fat diet on PGC-1α-dysregulated mutants. Zebrafish were anesthetized using 
tricaine solution (100mg/L) to record initial weights and lengths prior to transfer to individual 
tanks in the recirculating system. Four treatments were derived by exposing each genotype to 2 
separate dietary regimes; referred to as ‘Standard’ and High-Fat’ diets. Both diets received an 
identical morning meal consisting of 5 Ziegler Complete Diet pellets and 5mg of hatched brine 
shrimp, with high-fat diet zebrafish receiving 2 extra 30mg portions of brine shrimp 4 and 8hrs 
after the initial morning meal. Zeigler pellets were always presented prior to brine shrimp to 
ensure that daily nutrient requirements were met. Recirculation was turned off for 15 minutes to 
allow zebrafish to eat ad libitum while preventing the removal of the brine shrimp, after which 
water circulation was restarted. On a weekly basis and prior to their daily morning meal, 
zebrafish were anesthetized in tricaine (100mg/L) for weight and length measurements to track 
individual growth throughout the experiment. On the final measurement day, zebrafish were 
humanely euthanized by a blow to the head and severance of the spinal cord. Muscle samples 
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were quickly dissected, frozen in liquid nitrogen, and stored in an ultra cold freezer prior to 
further manipulation. In total, the experiment was repeated 5 times yielding 54 individual 
zebrafish (15 WT-Standard, 12 WT-High-Fat, 11 M-Standard, 16 M-High-Fat) that were 
analyzed both together and separated by sex (Male – 6 WT-Standard Female, 8 WT-High-Fat, 8 
M-Standard, 8 M-High-Fat and Female – 9 WT-Standard, 4 WT-High-Fat, 3 M-Standard, 8 M-
High-Fat) . The Fulton’s Conditioning Factor (hereafter referred to as the K-value) was 
calculated for each time point by relating overall mass and length measurements using Equation 
1 (Mozsár et al., 2015).  
𝑀𝑎𝑠𝑠 (𝑔)  × 100
𝐿𝑒𝑛𝑔𝑡ℎ (𝑐𝑚)3
= 𝐾 𝑉𝑎𝑙𝑢𝑒 
Equation 1: Calculation for determining the Fulton’s Conditioning Factor (K-Value) of individual zebrafish. 
3.3.6 Metabolomics  
Tissue samples obtained from the standard/high fat diet zebrafish were pulverized in liquid 
nitrogen and weighed to obtain the wet mass of the isolated tissues. The tissues were then 
dehydrated for 2 hours at -50°C and 0.05mBar using a FreeZone® 4.5 Liter Freeze Dry System 
(Labconco, Kansas City, USA). Tissue samples were then removed and weighed an additional 
time for evaluation of dry-mass tissue values. Both wet and dry mass tissue values were used to 
calculate the water content of the muscle tissue for each sample. Freeze-dried tissue samples 
were then packaged and shipped to University of North Texas for biomass sequential extraction 
(Gas Chromatography, UV Spectrophotometry and Liquid Chromatography). These methods 
were used to identify total protein/fat content as well as the individual levels of saturated FAs 
(SFAs), mono-unsaturated FAs (MUFAs), poly-unsaturated n-3 FAs (n-3 PUFAs) and 
polyunsaturated (n-6) FAs (PUFAs). The resulting dataset was also analysed using 
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MetaboAnalyst Software to perform statistical tests on FA levels and Debiased Sparse Partial 
Correlation (DSPC) network analysis to identity upregulated pathways impacted by FA changes. 
An additional DSPC guided analysis modeled a disease network using human data to identify 
increased metabolic disease susceptibility induced by dietary changes (Pang et al., 2020; Xia et 
al., 2011).  
3.3.7 Statistical Methods 
The data obtained from the yolk assay, zebrafish high-fat diet experiment and post-prandial O2 
consumption were analysed using SigmaPlot 14.0 (Systat Software, San Jose, USA). Yolk size 
and fluorescence data was compared using the Student’s t-test for each comparison (p = 0.05). 
Zebrafish lengths, masses and K-values were analysed using Two-Way ANOVA tests with 
parametric Holm-Sidak post-hoc tests for datasets passing normality and equal variance. Datasets 
that did not meet these conditions were exponentially transformed and datasets that still failed to 
meet these conditions were subjected to non-parametric tests instead. Post-Prandial data was 
examined by using Two-Way ANOVA Repeated Measures ensuring normality and variance 
once again before adhering to parametric post-hoc tests, with overall O2 consumption evaluated 
with matched hourly comparisons (p < 0.05). The overall maximum peak was identified by 
comparing the 4-hour (highest) and 10-hour (lowest) readings irrespective of genotype, with 4-
hour and 7-hour measurements serving as notable peaks of metabolic activity due to having 
increased statistical significance (p < 0.01) between genotypes at the same time period. 
Metabolic data analysis was handled by the MetaboAnalyst software using the Two-Factor 
analysis method after normalization by log transformation and range-scaling of the dataset. All 
FA comparisons were conducted using Two-Way ANOVA Type 1 comparison models. 
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Individual FAs were normalized by first applying a log transformation to all values followed by 
range scaling, while subclass FAs were normalized according to the median of the dataset. 
3.4 Results 
3.4.1 Larval Zebrafish Heartrate is Decreased During Early Development 
Mutant zebrafish larvae showed decreased heart rates in comparison to wildtype larvae initially, 
however no difference in heartrate was found by the end of the experiment (Figure 3-1A). The 
largest difference between the two genotypes was apparent at 4DPF where mutant heart rate was 
5.3% lower than that of the wildtype group. By 5DPF, heart rate in mutant had recovered and 
was indistinguishable from the wildtype group. At 6DPF, the heart rates of both genotypes 
increased slightly from 5DPF values but showed no differences according to genotypes. Overall, 
wildtype zebrafish had a lower variance of heart rate in comparison to the mutant zebrafish 
during each of the experimental time points.  
3.4.2 Larval Yolk Size is Larger in Mutant Zebrafish and Displays Higher Lipid Content  
Mutant zebrafish experienced a noticeable decrease in lipid abundance over a 3-day period 
(Figure 3-1B). Nile Red fluorescence decreased with each subsequent day allowing for 
individual lipid consumption tracking by direct comparison to the 4DPF timepoint. Although 
lipid fluorescence decreased daily in all treatments, mutant zebrafish maintained higher lipid 
content in comparison to their wildtype counterparts. When comparing 5DPF and 6DPF Nile 
Red fluorescence values to the initial 4DPF timepoint (5DPF/4DPF, 6DPF/4DPF), mutant 
zebrafish experienced less decay in fluorescence than wildtypes. While yolk sac size was similar 




3.4.3 Mutant Zebrafish Maintained Higher O2 Consumption and Displayed an Increased SDA 
Window After Consuming a High-Fat Meal 
Mutant zebrafish had an overall increased metabolic scope in comparison to wildtype fish after 
feeding on a morning meal of high-fat Artemia nauplii. Mutant zebrafish had a higher average O2 
consumption rate (48.19 ±3.11µmol/g/hr) than wildtype zebrafish (25.72 ±1.29 µmol/g/hr) over 
the entire 10-hour period. All hourly measurements were determined to be significantly different 
between the two treatments except for the 1-hour 10-hour timepoints (p < 0.05), with 2 notable 
peaks occurring at the 4 and 7-hour time points in the mutant treatment (p < 0.01) (Figure 3-2). 
We could not detect significant differences between hourly measurements within each treatment, 
however oxygen consumption rates at hour 4 and hour 10 irrespective of genotype were 




Figure 3-1: Mutant zebrafish larvae experience decreased heartrate, decreased yolk size and increased yolk lipid content 
during early development. A) At 4DPF, mutant zebrafish larvae experienced a 5.28% lower heart rate when compared to 
wildtype zebrafish (p = 0.019). B) Yolk fluorescence at 5/6DPF was compared to the initial fluorescence values at 4DPF. Mutant 
zebrafish yolk had 6.3% higher fluorescence readings at 5DPF (p = 0.05), with 9.04% higher fluorescence readings at 6DPF (p = 




Figure 3-2: Mutant zebrafish have a higher post-prandial O2 consumption rate following a high-fat meal. All timepoints 
between Wildtype and Mutant zebrafish were deemed significant following Two-Factor ANOVA Repeated Measurement 
analysis, except for the 1-hour and 10-hour timepoints (p = 0.05), with higher significance identified at the 4-hr and 7-hr 
timepoints (p = 0.001). Timepoint comparisons, irrespective of genotype, between the 4-hr (a) and 10-hr (b) timepoints were also 
identified as significantly different (p = 0.05). 
 
3.4.4 Adult Mutant Zebrafish Show Decreased Mass and Length Increases in Response to a 
High-Fat Diet  
Mutant zebrafish displayed impaired growth despite maintaining mass and length increases 
throughout 3-week experimental period and experienced minimal gains in the presence of a high-
fat diet. Irrespective of diet and sex, we found that mutant zebrafish were shorter than their 
wildtype counterparts at week 2 and week 3 (p <0.001 and 0.002 respectively, Figure S2). In 
general, WT-High-Fat zebrafish experienced the largest longitudinal growth (+11.4%) followed 
by WT-Standard diet zebrafish (+10.2%), M-High-Fat zebrafish (+8.5%) and finally M-Standard 
zebrafish (+6.6%). Interestingly, female M-High-Fat zebrafish were longer than M-Standard diet 
zebrafish (+4.9%), but this trend was reversed amongst male zebrafish as M-High-Fat zebrafish 
were shorter than M-Standard zebrafish (-3.7%). Despite this male-specific trend, we were only 
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able to detect diet-induced changes between our treatments in our female cohort at week 2 (p = 
0.027, Figure 3-3).  
With respect to zebrafish mass, we found that mutant zebrafish were significantly smaller than 
wildtype zebrafish across all weigh-in periods. Irrespective of sex, we found that WT-High-Fat 
zebrafish maintained the highest mass increases at week 3 (+48.3%) followed by M-High-Fat 
(+41.3%), WT-Standard (+34.4%), and M-Standard zebrafish (+14.6%, Figure S3). Interestingly, 
we noticed that female WT-Standard and M-High-Fat zebrafish masses converged at week 3 
where they became indistinguishable from one another. A similar phenomenon occurred amongst 
male zebrafish between M-High-Fat and M-Standard zebrafish, as both zebrafish gained similar 
amounts of weight by the end of the experimental period (Figure 3-4). Similar to length 
comparisons, we found that female zebrafish mass was greatly impacted by the inclusion of a 
high-fat diet especially due to mass increases amongst WT-High-Fat diet zebrafish. 
Finally, we compared the K-value of individual zebrafish to quantify the effect of genotype and 
diet on the health of individual zebrafish. By week 3, sex-independent K-value increases largest 
were highest amongst WT-High Fat zebrafish (14.9%) followed by M-High-Fat zebrafish 
(+10.9%), WT-Standard zebrafish (+4.5%) and finally M-Standard zebrafish (-2.9%). Overall, 
we found that genotype had a negligible effect on the K-value of our zebrafish in comparison to 
diet (Figure S4). The effect of diet was most evident amongst female zebrafish, specifically in 
WT-Standard zebrafish that continued to increase throughout the experiment in comparison to 
the other three treatments. With male zebrafish, we observed very few differences across all 
treatments and failed to identify dietary-induced differences until the final measurement point 




Figure 3-3: Sex and genotype effect on length growth in zebrafish fed standard and high-fat diets for 3-weeks. a) Male 
zebrafish experienced genetic-based differences in length at Week 2 (p = 0.006) and Week 3 (p = 0.016). B) Female zebrafish 
experienced diet and genetic linked mass differences at Week 2 (Diet p = 0.027, Genetic p = 0.06), with genotype differences at 





Figure 3-4: Individually tracked mass increases in both male and female zebrafish in response to standard and high-fat 
diets over a 3-week period. a) Male zebrafish experienced genetically induced mass differences at Week 2 (p = 0.011) and 
Week 3 (p = 0.004). B) Female zebrafish experienced dietary linked mass differences at Week 1 (p = 0.06) with diet and 
genetically induced differences at Week 2 (Diet p = <0.001, Genetic p = 0.002) and Week 3 (Diet p < 0.001, Genetic p < 0.001). 




Figure 3-5: Condition factor increases in both male and female zebrafish in response to standard and high-fat diet over a 
3-week period. a) Male zebrafish experienced dietary-induced K-Values at Week 2 (p = 0.032). b) Female zebrafish experienced 
dietary linked differences in K-Values at Week 1 (p = 0.03), Week 2 (p = 0.002) and Week 3 (p = 0.004). Significance markings 






Regardless of diet and genotype, all male zebrafish in our study had similar levels of total 
fat/protein content, however there were notable differences when examining the FA subclasses 
between high-low fat diets. Saturated FAs and poly-unsaturated (n-3) FAs were increased in 
response to a high fat diet, with decreased poly-unsaturated (n-6) FAs and no detectable 
difference found in mono-unsaturated FAs (Table 3-1). Of the 25 individual FAs measured in 
this study, 8 FAs (1 SFAs, 2 MUFAs, 4 PUFAs-3, 1 PUFA-6) were found at increased levels in 
high-fat diet zebrafish while 12 FAs (5 SFAs, 3 MUFAs, 1 PUFAs-3, 3 PUFAs-6) were 
decreased when compared to low fat diet zebrafish (Figure 3-6 & Table 3-2). Although we were 
unable to find differences in FA composition solely based on genotypes, we found that DGLA 
(Dihomo-gamma-linolenic acid; C20:3n6) was decreased in mutant zebrafish exposed to the 
high-fat diet. 
Following DSPC metabolite network analysis we uncovered 19 enriched metabolic pathways, 
the most prominent being increased biosynthesis of Unsaturated Fatty Acids (UFAs) (P = 
4.0x10-8) and increased glycolysis/gluconeogenesis (p = 1.81x10-5). In addition, FA restructuring 
pathways (FA biosynthesis p = 0.0226, FA elongation p = 0.0288 and FA degradation p = 
0.0392) and sugar metabolism pathways (Glyoxylate and dicarboxylate metabolism p = 0.00379, 
Amino sugar and nucleotide sugar metabolism p = 0.0228, Galactose metabolism p = 0.0404) 
were also highly prominent in our dataset (Table 3-3). The extended DPSC disease network 
analysis identified 4 metabolic diseases (schizophrenia, isovaleric acidemia, hypertension and 
stroke) that were influenced by 6 of the previously mentioned enriched metabolic pathways 
(Figure S5). The most significant risk factor associated with all 4 metabolic diseases was the 











Table 3-1: Total FA subgroups altered by either diet or genotype. Saturated FAs and PUFAs (n-6) were decreased, whilst 
PUFA (n-6) were increased in response to a High-Fat diet, with no overall differences being attributed to genotype. The overall 
abundance of FA subgroupings was determined via GC-MS/LC-MS and were thereafter normalized (log transformation, range 
scaled) and compared via Two-Factor ANOVA by MetaboAnalyst. The interaction between Diet and Genotype was determined 

























































Table 3-2: Individual FAs altered by either diet or genotype. A total of 19 FAs were affected by diet whilst 1 FA was affected 
by both diet and genotype. The overall abundance of individual FAs (%) were determined via GC-MS/LC-MS and were 
thereafter normalized (log transformation, range scaled) and compared via Two-Factor ANOVA by MetaboAnalyst. The 
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Table 3-3: Summary table of metabolite-metabolite network analysis. A total of 19 metabolic pathways were upregulated in 
zebrafish fed with the high-fat diet. Metabolite-metabolite associations were obtained using MetaboAnalyst using the 
MetPriCNet module with data from the STITCH database. 



















32 1.57 6 0.00379 
Riboflavin 
metabolism 
4 0.197 2 0.0134 
 
Citrate cycle (TCA 
cycle) 








46 2.26 6 0.0226 
Arginine 
biosynthesis 
14 0.689 3 0.0282 
Fatty acid elongation 36 1.77 5 0.0288 
Amino sugar and 
nucleotide sugar 
metabolism 
36 1.77 5 0.0288 
Glycerophospholipid 
metabolism 
36 1.77 5 0.0288 
Arachidonic acid 
metabolism 
36 1.77 5 0.0288 
Fatty acid 
degradation 
39 1.92 5 0.0392 
Galactose 
metabolism 
27 1.33 4 0.0402 
Glycerolipid 
metabolism 
16 0.787 3 0.0404 
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28 1.38 4 0.0451 
Glutathione 
metabolism 
28 1.38 4 0.0451 
 
3.5 Discussion 
Our experiment focused on examining the impact of altered PGC-1α expression on the growth 
and metabolic function of larval and adult zebrafish. Our initial characterization of mutant PGC-
1α zebrafish revealed increased basal metabolic rates during the juvenile life stage, alongside 
increased mitochondrial activity and lipid transport in adult white muscle tissue (see Chapter 2). 
Since an increase in basal metabolism reduces the amount of energy used for other physiological 
processes, we hypothesized that our PGC-1α mutant would exhibit stunted growth in comparison 
to wildtype zebrafish. Furthermore, as PGC-1α is commonly associated with mediating energetic 
demand, we sought to determine whether PGC-1α zebrafish displayed increased rates of FA 
metabolism and how growth may be impaired following a standard zebrafish diet compared to a 
high-fat diet.  
3.5.1 Mutant Zebrafish have Larger Yolks with Higher Fluorescence Values (Increased Lipid 
Content), But Also Display Decreased Heart Rate  
We first assessed growth and FA utilization in zebrafish embryo by tracking individual lipid 
consumption in the larval yolk sac. The zebrafish has served as a well-known model for 
developmental growth due to its transparent chorion and rapid growth following fertilization. 
These processes rely on the nutrient-rich yolk sac provided by the mother, a finite energy 
resource rich in lipids and protein content (Sant & Timme-Laragy, 2018). For these reasons, 
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larval zebrafish have become a useful model in the study of lipid metabolism and dyslipidemias 
(Miyares et al., 2014). One advantage of the zebrafish model is the ability to view lipophilic dyes 
through the transparent chorion to monitor lipid consumption. Furthermore, these dyes can also 
be visualized in laterally orientated zebrafish larvae allowing for yolk size and lipid fluorescence 
to be accurately measured by area measurements (Minchin & Rawls, 2017; Tingaud-Sequeira et 
al., 2011). We used 4-6dpf fish to focus on rapid growth and nutrient uptake, as the 3dpf 
timepoint provides consistent lipid content amongst siblings and prolonging our measurement 
period past 6dpf would result in yolk sac depletion (Jones et al., 2008). We observed decreased 
lipid consumption and larger yolk sacs in mutant zebrafish across all timepoints, suggesting that 
overall nutrient usage (and lipid-specific usage) is impaired by our PGC-1α mutation. These 
results contrast with our previous findings in PGC-1α adult mutants that had increased 
mitochondrial content and CPT-1/2 transporters in skeletal muscle, suggesting that the function 
of PGC-1α may change with development (see Chapter 2). The zebrafish yolk is rich in lipid 
content making it an adequate fuel source for β-oxidation (Fraher et al., 2016; Quinlivan & 
Farber, 2017), yet we observed decreased fat consumption across the 3-day development period 
with no increases in developmental fatality or deformations  
In addition to measuring larval nutrient consumption, we also monitored the heart rate of larval 
zebrafish to assess cardiac performance. The transparency of zebrafish larvae greatly benefits the 
study of cardiac development by allowing for non-invasive monitoring of heart rate, cardiac 
output and structural deformities making the zebrafish an excellent model organism for studying 
cardiac function (Asnani & Peterson, 2014; Genge et al., 2016). Cardiac development is 
paramount to embryo development due to its ability to translocate nutrients and oxygen 
throughout the zebrafish embryo, becoming apparent at 24hpf, structurally complete at 72hpf, 
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and fully functional by 92hpf (Dyballa et al., 2019; Kimmel et al., 1995). Indeed, the heart plays 
an important role in mediating growth during early development in both zebrafish and amongst 
other vertebrates by promoting angiogenesis and the creation of new tissue mass associated with 
organogenesis (Burggren, 2013; Goenezen et al., 2012; Pelster & Burggren, 1996). As larval 
zebrafish receive adequate blood oxygenation by diffusion, we believe that our experimental 
timeframe presents a unique environment where heart-specific PGC-1α activity can be linked to 
individual growth impairment in individual zebrafish larvae.  
Our results demonstrate that mutant zebrafish experience lower heart rates at 4DPF but quickly 
recover at 5DPF, resulting in near-identical heart rates consistent with previously reported values 
(Gore & Burggren, 2012; Kopp et al., 2005). The ability for larval zebrafish to recover and 
match the heartrate of wildtype zebrafish is intriguing, as PGC-1α-deficient mice face lifelong 
cardiac impairment with decreased heart size, heart rate and cardiac output, with conflicting 
results suggesting altered mitochondrial density (Arany et al., 2005; Leone et al., 2005). 
Previously, we examined the mRNA transcripts of our mutant zebrafish line and found that adult 
zebrafish PGC-1α mutants have profound alterations in gene expression of several regulators 
(ERRα, NRF-1, PPARα, and PGC-1β), reminiscent of PGC-1α-knockout mice, however no 
mitochondrial transcripts were altered suggesting that mitochondrial density in the zebrafish 
heart is unchanged (see Chapter 2). Overall, it appears that PGC-1α still plays an important role 
in the larval zebrafish heart, however we suspect that this mechanism is different from that 
observed in mammalian species. 
3.5.2 Mutant Zebrafish Have a Higher Metabolic Rate After Consumption of a High-Fat Meal  
Considering the effects of the PGC-1α mutation on yolk metabolism, we wanted to assess 
whether adult zebrafish would have similarly altered metabolism following a high-fat meal. We 
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starved adult zebrafish 24-hrs prior to feeding them a high-fat meal (600mg of Artemia) to 
observe individual metabolic rates following a high-fat meal. Food consumption leads to 
increased energy expenditure and heat production due to digestion processes such as enzymatic 
activity, macromolecule breakdown and nutrient adsorption (Chabot et al., 2016). These 
processes, referred to as Specific Dynamic Action (SDA) start immediately after feeding and last 
up to 72hrs, with the energetic peak appearing more prominently when food intake is high and 
the animal is leaner (Chabot et al., 2016; Feher, 2017). Despite this extensive time period, the 
majority of energetically intensive digestion occurs during the first 8-hours following meal 
consumption. To capitalize on this timeframe, we allowed individual zebrafish to feed for 15-
minutes ad libitum before immediate transfer to the respirometry system. Our results indicated 
that PGC-1α mutant zebrafish experience a near two-fold increase in metabolic activity across 
the entire post-prandial period, with an additional SDA-peak near the end of the experimental 
window.  Although the timing of peak SDA activity can vary between species and meal quality, 
we found that our 10-hour window was sufficient for examining peak O2 consumption in 
zebrafish (Chabot et al., 2016; Fu et al., 2005). Furthermore, our wildtype zebrafish had similar 
SDA O2 consumption rates observed before, and was 20% higher than previously documented 
basal metabolic rates, despite immediate transfer of the zebrafish into the respirometer after the 
initial feeding period (Ferreira et al., 2019; Lucas & Priede, 1992; Silva, 2013). 
Our initial characterization of PGC-1α mutant zebrafish described a 2-fold increase in the resting 
metabolic rate of juvenile zebrafish, however our examination of the SDA peaks show that fat 
metabolism is also increased by altered PGC-1α expression. Irrespective of genotype, both the 4-
hour (peak) and 10-hour (constant) time points were significantly different, suggesting the 4h 
mark represents SDA peak activity for both treatments. We also found that mutant zebrafish had 
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a prolonged SDA period with an additional peak present at the 7-hour time point suggesting that 
the duration of SDA activity is nearly doubled in mutant zebrafish. Overall, these factors suggest 
that mutant zebrafish have increased metabolic activity during the post-prandial window and 
further supports the notion that PGC-1α plays a key role in zebrafish fat-metabolism. 
3.5.3 Mutant Adult Zebrafish Resist Growth with Decreased Length and Mass, Even When 
Fed High-Fat Diet 
An effective method of encouraging growth in adult zebrafish is to increase the daily amount and 
frequency of Artemia feedings. Artemia have long been used as a laboratory feed for zebrafish 
due to their high fat and protein content, with overconsumption resulting in rapid onset of obesity 
(Landgraf et al., 2017; Léger et al., 1987; Oka et al., 2010). The increased consumption of 
Artemia increases daily caloric intake that may contribute to growth or become stored as internal 
fat reserves. To account for these aspects, we recorded the length and mass of individual 
zebrafish over a 3-week period. Length and mass measurements are commonly used to represent 
overall health in laboratory experiments and serve as base metrics for growth in nutrition-based 
studies, allowing for us to find comparable mass and lengths for both our standard and high-fat 
diet wildtype zebrafish (Landgraf et al., 2017; Parichy et al., 2009). Overall, we found that 
mutant zebrafish were lighter and shorter than mutant zebrafish, suggesting that mutant zebrafish 
are smaller in both metrics even when provided with additional food. (Lugert et al., 2016). Upon 
seeing these differences, we hypothesized that these mass increase rates may have adverse 
affects on zebrafish health. Certainly, progressive or ‘natural’ growth is a characteristic of good 
health but delayed or rapid growth in response to nutrient availability can lead to reduced 
physical activity or increased susceptibility to metabolic syndrome (Kern & Mitmesser, 2018; 
Novak et al., 2005).  
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Moving forward, we decided to examine the K-values of individual zebrafish to see if overall 
health was impaired by either PGC-1α dysfunction or the presence of a high-fat diet. Typically, 
the K-value is used as an indicator of overall fish energy reserves, where K ≥ 1 indicates that an 
organism has excess energy. However, the K-value can also provide an effective estimation of 
fat content in freshwater fish indiscriminately of both protein and water content (Mozsár et al., 
2015). Therefore, decreased K values may indicate starvation or malnutrition and increased K 
values may represent onset obesity. Unsurprisingly, both genotypes experienced increased K-
values when subjected to the high-fat diet likely due to the increased FA intake, approaching 
previously reported values (Landgraf et al., 2017). No significance was attributed to genotype for 
either female or male zebrafish, however wildtype fish appeared to be more susceptible to K-
factor increases when subjected to the high-fat diet. In particular, female WT-High-Fat fish 
experienced a near 2-fold increase in K-value when compared to M-High-Fat zebrafish. Sex-
linked differences in response to high-fat diets have been previously identified in zebrafish and 
other higher vertebrates (Hwang et al., 2010; Navarro-Barrón et al., 2019) likely because of 
reproductive activity such as oocyte production, resulting in increased mass gains due to excess 
nutrient availability (Augustine et al., 2011; Quinlivan & Farber, 2017). This suggests that our 
dietary differences in weight gain may be due to increased clutch sizes in wildtype zebrafish due 
to excess lipid intake and that mutant female zebrafish experience higher levels of fat 
metabolism and therefore have decreased lipids available for oocyte production. Therefore, our 
findings suggest that PGC-1α dysregulation has strong metabolic implications for female 
zebrafish, however these sex-specific traits are difficult to explain based on body mass gains 
alone and therefore would warrant further investigation. With these differences in mind, we 
focused our metabolic analysis exclusively towards male zebrafish skeletal muscle tissue. 
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3.5.4 Overall Fat and Protein Content is Similar Between Treatments, but Individual FA 
Content is Impacted by Both Diet and Genotype. 
The metabolomic profile of high-fat zebrafish resembles that of the Artemia feed with decreased 
levels of non-essential FAs (SFAs and MUFAs) and increased essential FAs (PUFAs). Although 
the nutritional profile of Artemia varies due to origin and enrichment processes, most Artemia 
sources tend to have low levels of SFAs (~20%), moderate levels of MUFAs (~32%) and high 
levels of PUFAs (~45%) (Chakraborty et al., 2007; Léger et al., 1987). Both SFA and MUFA are 
classified as non-essential fatty acids due to their ability to be biosynthesized in vivo, however 
their representation, particularly in the case of SFAs may signify lipid metabolism disorders. 
Indeed, increased SFA levels in muscle tissue can lead to localized inflammation and increased 
insulin resistance following the disruption of PGC-1α activity, both resulting in obesity and 
further metabolic disruption in mammals (Kennedy et al., 2009). We found that our high-fat diet 
zebrafish had decreased levels of SFAs with negligible changes in MUFAs, suggesting that 
wildtype male zebrafish may have experienced healthy levels of growth in the presence of high-
fat overfeeding.  
Zebrafish also exhibited a shift amongst essential fatty acids when exposed to a high-fat diet, 
with decreased levels of n-6 PUFAs and increased levels of n-3 PUFAs. Freshwater fish are 
naturally rich in n-6 PUFAs but ad libitum feeding of Artemia presumably increased n-3 PUFAs 
amongst high-fat diet zebrafish, which may promote anti-inflammatory processes and provide 
protection against metabolic diseases (Cheng et al., 2015; Sahena et al., 2009). Various studies 
have shown that n-3:n-6 imbalances are found in a number of metabolic diseases such as chronic 
obesity, CVD and depression (Dinicolantonio & O’Keefe, 2018; Fowler et al., 2020). 
Furthermore, the beneficial effects of n-3 PUFAs also extend to decreased weight loss in 
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mammals, an effect also seen in female zebrafish using fish oil supplementation (Huang et al., 
2016; Meguro & Hasumura, 2018). Although most of the n-3 PUFAs were increased in response 
to a high-fat diet, we found that C22:6n3 (Docosahexaenoic acid; DHA) levels were decreased as 
well. Docosahexaenoic acid is the longest n-3 PUFA and is commonly regarded as an 
‘evolutionary pacemaker’ due to its beneficial properties supporting oxidative metabolism. 
Animals with higher metabolic rates have increased levels of DHA in their plasma membranes, 
which may raise β-oxidation rates by increasing ion permeability in the mitochondria (Manzi et 
al., 2015; Price et al., 2018). Although generally n-3 levels were higher in the high-fat diet, 
decreases in DHA could indicate a decreased metabolic capacity allowing for rapid weight gain 
that may result in obesity and FA imbalances with continued feeding. 
While we were unable to find any individual FAs that were solely impacted by PGC-1α-
dysregulation, DGLA levels were significantly decreased in mutant zebrafish and high-fat diet 
zebrafish. Dihomo-gamma-linolenic acid is a n-6 PUFA originating from either dietary intake or 
the elongation of Gamma-linolenic acid (C18:3n6) (Sergeant et al., 2016). Afterwards, DGLA is 
actively converted into various eicosanoids that help regulate immunological and metabolic 
processes locally; increasing adipogenesis and FA translocase/CD36 activity by PPARγ/α 
activation in mice (Dennis & Norris, 2015). Additionally, DGLA is also reducing proton leakage 
in the inner mitochondrial membrane, increasing mitochondrial efficiency by reducing O2 flux 
associated with proton re-entry (Brand & Nicholls, 2011; Gallagher et al., 2019). In our previous 
work we found increased O2 flux in PGC-1α mutant white muscle tissue with fully saturated 
mitochondria but observed no further change in O2 flux following mitochondrial uncoupling. 
Therefore, it is possible that mutant zebrafish experience increased proton leakage, effectively 
increasing their basal metabolic rate and limiting their energetic surplus required for growth. 
78 
 
To gain further insight on the metabolic pathways affected by the high-fat diet, we mapped our 
metabolic dataset using DSCP analysis. Multiple FA specific pathways (FA biosynthesis, 
lengthening and breakdown) were upregulated and likely responsible for the shift from n-6 
PUFAs to n-3 PUFAs alongside decreased SFA levels. Coincidentally, decreased SFAs may also 
explain why increased glucose production (glycogen breakdown and gluconeogenesis) was also 
reported by the network analysis, as high SFA levels lead to insulin resistance in muscle tissue 
(Sears & Perry, 2015). The additional metabolic pathways upregulated by the high-fat diet show 
increases in nutrient catabolism through the metabolism of riboflavin, pyruvate and various 
amino acids, lipids and simple sugars. Ultimately, these pathways indicate that our high-fat diet 
promotes growth by providing increased usage energy to both mutant and wildtype zebrafish. 
As increased nutrient intake can lead often to unfavourable metabolic diseases later on in life, we 
decided to model our high-fat diet dataset to create a predictive disease-network to identify 
increased risk to metabolic diseases. Although our network analysis relies on a human-orientated 
database and lacks tissue specificity, similarities between zebrafish and human signalling 
pathways are explored extensively in biomedical studies (Goldsmith & Jobin, 2012; Seth et al., 
2013). In addition, skeletal muscle serves as one of the final storage depots for excess FAs, 
suggesting that these levels could be considered as ‘conservative estimates’ for other tissues such 
as adipocytes (Hausman et al., 2014). Overall, the high-fat diet FA profile was associated with 
four different disorders with a high predictability regarding schizophrenia and fewer relations 
regarding isovaleric acidemia, hypertension and stroke. We failed to observe any behavioural 
differences amongst individual zebrafish, however human schizophrenia patients share similar 
clinical markers with obesity; such as high SFA levels, increased insulin resistance and low 
DHA levels in brain tissue (Dipasquale et al., 2013; Peet, 2004; Sakai et al., 2018). Isovaleric 
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acidemia is a genetic disease characterised by the inability to properly metabolize leucine and is 
unlikely to be present amongst our mutant zebrafish. However, increases in leucine levels can 
promote weight loss, lean muscle growth and oxidative glucose metabolism in skeletal muscle 
(Binder et al., 2014; Layman & Walker, 2006). The remaining two diseases, hypertension and 
stroke, suggest that a high-fat diet would have adverse physiological effects on the zebrafish 
heart, however it is currently unknown how these pathologies would affect mutant zebrafish with 
silenced PGC-1α expression in the heart.  
3.6 Conclusion 
PGC-1α plays an important role in the regulation of mammalian metabolism and growth, 
however this relationship has not been fully addressed amongst lower vertebrates. In periods of 
nutrient limitation, mammalian PGC-1α maintains basal metabolism by upregulating FA 
metabolism in the mitochondria, effectively reducing growth while maintaining adequate energy 
supply. Using our newly established zebrafish PGC-1α model, we have confirmed that many of 
these processes are present in a teleost fish species. Overexpression of PGC-1α in adult zebrafish 
muscle tissue increased FA metabolism during the post-prandial period and decreased overall 
growth in response to a standard and high-fat diet. Decreased DGLA levels amongst mutant 
zebrafish suggests that mitochondrial leakage may release excess energy liberated from 
increased FA metabolism as the underlying mechanism of PGC-1α growth impairment. 
Conversely, the larval phenotype depicting delayed lipid metabolism suggests that growth may 
still be impaired, likely through a different mechanism as shown in the later adult stages. This 
suggests that PGC-1α may have additional relationships with growth and metabolism that clearly 




Chapter 4: Conclusion 
4.1 Apparent Evolutionary Similarities and Differences Between Teleost and 
Mammalian PGC-1α  
The PGC1 family of co-activators has demonstrated a crucial importance in the regulation of 
metabolic activity in mammalian species, however few studies have examined these regulatory 
roles in other vertebrates including fishes. The few studies on fish PGC1 collectively suggest 
that the coactivator contains distinct structural differences with potentially divergent roles to that 
of mammalian PGC-1α, presenting the need for a genetically modified fish model to further 
investigate the function of this regulator. Using CRISPR technology, I created a mutant zebrafish 
line displaying a unique PGC-1α expression profile with PGC-1α overexpression in skeletal 
muscle tissue and down-regulated PGC-1α expression in heart tissue. Additionally, using a 
variety of genetic and physiological techniques, I characterized the metabolic phenotypes 
associated with the disruption of PGC-1α in this new biomedical model.  
In the 1st study, I disrupted a newly discovered evolutionary conserved region that controls PGC-
1α expression in the heart and skeletal muscle tissue of the zebrafish. Hence, this mutation 
allowed for the examination of tissue-specific patterns of PGC-1α-mediated pathways in the 
zebrafish for comparison to previous mammalian PGC-1α studies. In response to decreased 
PGC-1α expression in heart tissue, PGC-1α-mediated transcription factors (ERRα and NRF-1) 
and the metabolic co-activator PGC-1β were downregulated, yet none of their downstream 
metabolic genes were presumably affected. Mammalian PGC-1α knockouts describe similar 
decreases in PGC-1α-mediated TFs (ERRα, NRF-1) that result in multiple metabolic side effects 
such as increased CPT-1/2 expression, reduced cardiac function and increased cardiac stress in 
later life stages (Arany et al., 2005). These phenotypes can be detrimental in mammals, however 
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the zebrafish heart has regenerative properties that could alleviate these potentially unwanted 
phenotypes (Asnani & Peterson, 2014; Gemberling et al., 2013). Although the identification of a 
cardiac-specific phenotype for our mutant zebrafish would have been ideal, the zebrafish heart is 
incredibly small and the few milligrams of tissue that we managed to isolate were not suitable for 
use in high-resolution respirometry. Due to these physical limitations and no alteration of 
effector genes in the heart tissue, the remainder of chapter 2 focused on the observation of PGC-
1α overexpression in skeletal muscle. 
The gene expression profile of mutant skeletal muscle tissue was surprising as PGC-1α-mediated 
TFs (ERRα, NRF-1, PPARα) expression were unaffected despite a 4-fold increase in PGC-1α 
expression. In PGC-1α-overexpressed mammalian models, these TFs are upregulated and 
increase the expression of the metabolism effector proteins (COX IV, CS, MCAD, FABP3 and 
CPT-1/2) (Supruniuk et al., 2017; Wende et al., 2007; Wu et al., 1999). In the mutant zebrafish, 
we found that CPT-1 and CPT-2 expression increased independently of PGC-1α-mediated TFs, 
suggesting that these mitochondrial proteins are regulated by an alternative pathway exclusive to 
the zebrafish. Increased CPT-1 and CPT-2 expression suggested that PGC-1α mutant zebrafish 
have an increased affinity for FA substrates, hence leading to the assessment of mitochondrial 
performance in isolated muscle fibres. Indeed, mutant zebrafish white muscle fibres displayed 
increased O2 consumption following maximum load of individual mitochondria, indicating 
increased mitochondrial abundance or decreased mitochondrial efficiency. Increased O2 
consumption was also observed amongst juvenile mutant zebrafish at rest, providing further 
evidence that mutant zebrafish face metabolic consequences due to PGC-1α disruption. 
Altogether, these muscle-based phenotypes suggest that PGC-1α retains its role as a master 
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regulator in zebrafish, despite alternative regulatory patterns as demonstrated in both the muscle 
and heart tissues.  
In my 2nd study, I utilized the newly established model to examine how altered PGC-1α 
expression may impact growth in the zebrafish. Decreased weight and size is a prominent 
phenotype amongst mammalian PGC-1α models and this phenotype may also persist amongst 
PGC-1α mutant zebrafish (Leone et al., 2005; J. Lin et al., 2004). During the larval stage, mutant 
zebrafish had a decreased heart rate with increased yolk-lipid content. These observations 
suggested that FA metabolism and growth were impaired in PGC-1α mutant zebrafish larvae, as 
yolk-derived lipids are vital for driving organogenesis during this critical developmental time 
point (Goenezen et al., 2012; Gore & Burggren, 2012). However, this decrease in FA 
metabolism was unexpected since CPT-1 and CPT-2 transcripts were upregulated in adult mutant 
muscle tissue, which provoked further investigation of FA metabolism in adult mutant zebrafish. 
Indeed, a 2-fold increase in O2 consumption was identified during the SDA period of adult 
mutant zebrafish following a high-fat meal, indicating that PGC-1α mutants have temporal shifts 
in their ability to metabolize FA substrates. This increased FA metabolism negatively impacted 
the growth of mutant zebrafish in our prolonged dietary experiment, where mutant zebrafish 
experienced minimal increases in length and mass in the presence of a standard diet. When 
presented with a high-fat diet, mutant zebrafish were still incapable of matching the rapid growth 
observed in wildtype fish. In fact, mutant zebrafish fed with a high-fat diet experienced similar 
growth increases as wildtype fish following our standard diet. When examining the metabolomic 
profile of mutant zebrafish muscle, we found decreased DGLA levels in mixed muscle tissue, a 
FA responsible for reducing proton leakage in the mitochondria. With a decrease in muscular 
DGLA, mutant zebrafish may experience increased mitochondrial leakage resulting in 
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heightened O2 consumption to maintain the hydrogen gradient required for ATP synthesis. 
Altogether, the information presented over these two chapters might suggest that the CPT-1 and 
CPT-2 proteins are upregulated to saturate the FA pathway of the mitochondria to maintain the 
proton gradient as a method for compensating the increased leakage found in the mitochondrial 
membrane. Alternatively, one could suggest that CPT-1 and CPT-2 proteins are upregulated in 
order to recover DGLA levels in the mitochondria of skeletal muscle, but ultimately face 
degradation before being incorporated into the mitochondrial membrane. 
4.2 Future Directives for the Study of PGC-1α in Zebrafish 
With additional research, the characterisation of the PGC-1α zebrafish model could certainly be 
further defined. Using mixed muscle fibres in our initial assessment of gene regulation restricted 
us from identifying fibre specific patterns, which clearly display different phenotypes in response 
to altered PGC-1α expression as demonstrated by high-resolution respirometry. Red and white 
fibres display opposing phenotypes in both fish and mammals, as red muscle is more oxidative 
and slow twitch, while white muscle is typically more glycolytic and fast twitch. Additionally, 
white muscle fibres greatly outnumber those of red muscle fibres, however red muscle fibres also 
contain a much higher density of mitochondria (Buss & Drapeau, 2000; Glancy & Balaban, 
2011). Hence, the separation of both red and while muscle fibre types to investigate differences 
in gene expression could have revealed differences that may have been obscured in this study.    
The generation of a true homozygous mutant PGC-1α line would allow for greater clarity in 
assessing the true roles of the zebrafish PGC-1α protein in both cardiac and skeletal muscle. In 
the work presented here, we utilized heterozygous mutants primarily due to time constraints to 
perform the initial characterization of the zebrafish line. As a result, the mutant zebrafish line 
examined here is comprised of a mixture of 3 unique deletions spanning 4-bp, 7-bp, and 13-bp 
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segments respectively across 6 regulatory elements associated with metabolic regulation. 
Conveniently, 5 of these regulatory elements appear to be disrupted, either entirely or partially 
by each of the 3 mutations apart from NFE2L1, a binding element for NRF-1 that remains 
uninterrupted by the 7-bp deletion. Despite this ambiguity amongst our mixed genotypes presentr 
in our mutant zebrafish line, we were still successful in identifying many phenotypes with the 
current model, such as decreased heart rate and lipid consumption in larvae, decreased overall 
growth and increased O2 consumption in juveniles and isolated white fibres and while these 
phenotypes help validate the establishment of this mutant model it is also possible that the 
integral roles of PGC-1α remain hidden due to genetic compensation by the wildtype PGC-1α 
promoter (El-Brolosy et al., 2019; El-Brolosy & Stainier, 2017). Using homozygous mutant 
zebrafish would also allow for simplified experimental design as it removes the need for 
individual genotype screening and provides more zebrafish for experimentation. Homozygous 
mutants would also provide increased reliability for high-throughput genetic assays, delivering 
rich datasets that can be computationally analyzed and catalogued to further build upon the 
phenotypes associated with PGC-1α pathologies (Kaliyappan et al., 2012; Z. Wang et al., 2009).  
Although our approach was successful in modifying PGC-1α-expression in both the heart and 
muscle tissue, other metabolically active tissues such as the brain and liver are equally relevant 
in the overall study of PGC-1α. Certainly, the investigation of PGC-1α in brain tissue would be 
beneficial to neurological decay and disease research as previous studies have indicated 
neuroprotective roles of PGC-1α in mammals (Tsunemi & La Spada, 2012; Zheng et al., 2010; 
Zheng et al., 2017). The liver is also heavily impacted by PGC-1α expression, directly 
controlling gluconeogenesis through the expression of hepatic insulin receptors (Besse-Patin et 
al., 2019). Additionally, the zebrafish gills may also be an area of interest considering that this 
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respiratory organ is absent in other vertebrates but maintains a high mitochondrial density 
(Dawson et al., 2020; Lin & Sung, 2003). Whole body PGC-1α knockouts may reveal additional 
phenotypes associated with inter-tissue PGC-1α signaling pathways, a recent discovery noted in 
mammalian models (Balampanis et al., 2019). Certainly, additional zebrafish PGC-1α models 
should be investigated for the continued research of PGC-1α in teleosts.  
Finally, one application of the work presented here is the implementation of this CRISPR-
induced mutation into other vertebrate models. The genetic region modified in the mutant 
zebrafish is highly conserved throughout vertebrate lineage and suggests that this CRISPR-
induced mutation could be easily incorporated into other vertebrates (reptiles, amphibians and 
birds) and mammalian species for the investigation of PGC-1α activity in skeletal muscle and 
cardiac tissues. Although the primary goal of this thesis was to identify divergent roles of the 
teleost PGC-1α protein, implementing this mutation in other model organisms would greatly 
accelerate our understanding of this co-activator in both an evolutionary and biochemical 
perspective. While multiple mammalian PGC-1α models have been established thus far, our 
model provides an interesting hybrid of increased muscle/heart expression that is currently 
unexplored. As such, it would be interesting to examine if this mutation presents viable offspring 
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Table S1: Primer list for CRISPR gRNA synthesis, HRM analysis and gene expression. Grey lettering indicates template 
regions required for the synthesis of the gRNA (black lettering).  
Primer Forward Primer (5’-3’) Reverse Primer (5’-3’) 
EF1α 15 GTGCTGTGCTGATTGTTGCT TGTATGCGCTGACTTCCTTG 
RPL 13a 15 TCTGGAGGACTGTAAGAGGTATGC AGACGCACAATCTTGAGAGCAG 
PGC1a 15 ACCAACCATCTTGCCACTTC ATTACTCAGCCTGGGCCTTT 
HOAD CCACAGGACATTCAGTGGTG GTCAGTGCCATGAACGACAG 
MCAD CAGAAAGAGTTCCAGGAGGTG TGTCCGTTCATTAGACCCAG 
ERRα AGATGTGGCATCTGGCTACC CCAAGCGAACTCCTTCTTTG 
NRF-1 AGGCCCTGAGGACTATCGTT GCTCCAGTGCCAACCTGTAT 
CS ATCCGTTTCCGTGGTTACAG AGACAGCCAACTGACCTGCT 
COX IV CAAGTTTGTGCAGCAGCTG CAAAGAAGAAGATTCCTGCAAC 
CPT1 TATGACCGTTCAGACGCAGA TACAGGCAGATGTGGCAGAG 
CPT2 AATGGATTGGGTGCAACGTG TGAGTTCTAACCTTCAGGCTC 
FABP3 TCAGCTCAAACATGGCAGAC CAAAGCCAACACCAATTCCT 
PPARα ACCAACCATCTTGCCACTTC ATTACTCAGCCTGGGCCTTT 










Table S2: Flux control ratios calculated by the DatLab analysis excel template to examine individual differences in 
mitochondrial performance. No significant differences were found when examining all substrate additions in both tissues.  































































CCCP  1  1  -  1  1  -  











Figure S1: Mutant zebrafish displayed altered melt curves serving as the initial characterization of the mutant line. 
Mutant zebrafish displayed either shift peaks (termed ‘Homozygous’, Red) or multiple peaks (termed ‘Heterozygous’, Orange) 
when compared to wildtype peaks (Black) in response to successful CRISPR-induced deletions. Homozygous zebrafish were 






Figure S2: Individually tracked length increases in mixed sex zebrafish in response to standard and high-fat diets over a 
3-week period. Zebrafish experienced dietary linked differences in length at Week 2 (p = <0.001) and genetic differences at 





Figure S3: Individually tracked mass increases in both male and female zebrafish in response to standard and high-fat 
diets over a 3-week period. Zebrafish experienced genotype linked differences in mass initially (p = 0.041) with dietary and 
genetic linked differences at Week 1 (Diet p = 0.012, Genotype p = 0.019), Week 2 (Diet 0.002, Genotype p < 0.001) and Week 3 
(Diet p < 0.005, Genotype = <0.001). Significance markings in red indicate the use of ranked testing for when normality and 




Figure S4: Individually tracked K-Value increases in both male and female zebrafish in response to standard and high-fat 
diets over a 3-week period. Zebrafish experienced dietary and genetic linked differences in K Value at Week 1 (Diet p < 0.001, 
Genotype p < 0.001) with genotype differences at Week 2 (0.027) and Week 3 (p = 0.009). Significance markings in red indicate 




Figure S5: Summary diagram of metabolite-disease network analysis. A total of 5 metabolic diseases were linked to 10 of 
the upregulated/downregulated FAs found in the high-fat diet zebrafish. 
